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1.1 Fetal lung development 
1.1.1 Five stages of fetal lung development 
Fetal lung development is a complex biological process which includes temporal and spatial 
regulation of multiple factors, such as growth factors, transcriptional factors and extracellular 
matrix (ECM). The development of the intimate relationship between airways and blood vessels is 
of crucial importance to the normal lung function. Morphologically, the rat lung development can 
be divided into 5 stages: Embryonic Stage (embryonic day 11.5 (E11.5) to E13), Pseudoglandular 
Stage (E13 to E18), Canalicular stage (E18 to E20), Sacular Stage (E20 to New born) and 
Alveolar Stage (New born to adult) (18; 25).  
During the embryonic stage, the lung buds first originate as a diverticulum from the foregut 
endoderm and gradually grow into the surrounding mesoderm, which forms a bifurcate tube 
composed of highly columnar epithelium (18). After one or two generations of successive 
bifurcate division, the lung forms a tubulo-acinar gland. 
The pseudoglandular stage in rat starts on embryonic day 13 and lasts for 5 days. This stage 
is marked with repeated dichotomous branching which establish almost all the geometric pattern 
of the conducting airways (13). The branching morphogenesis during this stage is achieved by 
inducing the bud from the outmost periphery of the epithelial tubes. As the lung originates, the 
pulmonary arteries bud off from the sixth pair of aortic arches and undergo the branching 
morphogenesis parallel to the airway tree (18). At this stage, the vascular system is separated 
from airway conducts by the mesenchyme and the capillaries are loosely lined into the 




After forming all the conducting airways, in the canalicular stage, several generations of more 
delicate primary and terminal bronchioles bud from the tips of the main bronchus. These primary 
bronchioles, together with their surrounding mesenchyme, represent the early acini for gas 
exchange. Simultaneously, the capillary networks readjust themselves and become more closely 
aligned with the distal cuboidal epithelium, where they form the early thin blood-gas barrier. 
However, during this stage, these acini do not have the ability to carry out gas exchange. Another 
marker of the canalicular stage is the development of the pulmonary epithelium. The columnar 
epithelial cells which are found typically in the peripheral airways become lowered in shape and 
change to cuboidal epithelial cells (79). The newly differentiated cells, known as alveolar epithelial 
type II cells (AEC II), are capable of secreting surfactant, which reduces the surface tension at the 
air-liquid interface.  
The last two stages for the lung development are the saccular and alveolar stages. The 
beginning of the saccular stage is characterized by relatively thin-walled terminal saccules which 
are produced by the last generations of branching (18). During the saccular stage, the distal 
epithelium undergoes substantial enlargement, which results in a significant decrease in 
interstitial tissue. The epithelium and mesenchyme both become thinner and thinner, which 
causes the capillary network to further rearrange itself. The capillaries closely accompany the 
airway epithelium, which results in a significant increase of the saccule vascularity. The epithelial 
cells are further flattened and differentiated into alveolar epithelial type I cells (AEC I) (79; 140). 
The AEC I closely line along the capillary endothelial cells to form a thin blood-gas barrier in the 
intersaccular septa. More surfactants are secreted by AEC II cells. However, compared to the 
mature lung, the interstitial layer at this stage has much fewer extracellular fibers and the lung 
only forms less than 10% of the total alveoli (18; 26).  
At birth, the lung develops functional sacs and acini which could support adaption to air 
breathing. However, the lung is not completely mature yet and still needs alveolarization to further 
increase the gas exchange area. One of the markers of the alveolar stage is repeated growth and 
separation of thousands of alveoli (19; 52). Elastin is continuously deposited underneath the 
epithelium to prepare for the generation of the secondary septa (18). The bulging of the new 
septa separates the original saccules and converts them into alveolar ducts, which gives rise to 
the new alveoli. The recurring alveolization dramatically increases the surface area for gas 
exchange. Simultaneously, the relatively thick septa are further attenuated and interstitial tissue is 
reduced. The capillaries are further rearranged and transformed into a single capillary network in 
the interalveolar septa, as observed in the mature lung. After completing alveolarization, the 
pulmonary system is more powerful for gas exchange. 
The mouse and human lung development can also be divided into these five stages. The 
pseudoglandular stage starts from E14 to E16 in mouse and E42 to E112 in human. The 

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canalicular stage is from E16.5 to E17.5 in mouse and E112 to E186 in human. The saccular 
stage initiates on E17.5 and to birth in mouse and from E196 to E252 in human. The alveolar 
stage continues from term to ~P15 in mouse and to until 2 years in humans (74).  However, some 
animals including rabbit, horse and sheep, complete the alveolarization and establish the majority 
of internal surface area before birth (31; 74).  
1.1.2 Alveolar epithelium 
The alveolar epithelium is the place where gas exchange occurs. AEC I and AEC II are the 
major components of distal airway epithelium and aid in the normal respiratory process.  
AEC I are large squamous cells covering about 95% of the alveolar surface area. They form 
the gas-blood exchange barrier and function in gas exchange and fluid transport (49; 72). AEC II 
are cuboidal and are normally located in the corners of alveoli. They occupy less than 5% of the 
alveolar surface area (74). AEC I are terminally differentiated and are prone to damage. When 
this happens, AEC II act as progenitor cells, differentiate into type I cells, and repair the damaged 
alveolar epithelium. AEC II also synthesize and secrete pulmonary surfactant, a lipid-rich 
lipoprotein complex that spreads on the surface of alveoli to form a thin lining layer and reduces 
the surface tension. The surfactant facilitates the normal gas exchange process by reducing the 
force against lung inflation and keeping the alveoli from collapse. Insufficient amount of 
pulmonary surfactant leads to abnormal lung functions (43; 143). 
Pulmonary surfactant is a heterogenous mixture containing 90-95% lipids and 5-10% 
proteins. The most abundant lipids are phospholipids, which contribute 80%. The other 
components of lipids include neutral and some other lipids. The most abundant phospholipids are 
phosphotidylcholine (PC) and phosphatidylglycerol (PG). PG is the last surfactant to be 
synthesized during development. The concentration of PG is normally assumed to be a marker of 
fetal lung maturity. 
There are four surfactant proteins: surfactant protein A, B, C and D (SP-A, -B, -C and -D). 
SP-B and SP-C are hydrophobic proteins, and are packed into storage granules called lamellar 
bodies together with lipids before secretion (34; 124). The secretion of pulmonary surfactant are 
regulated by various molecules, such as intracellular Ca2+, P2Y2 receptor agonists (ATP and 
UTP), adenosine, platelet activating factor, and IL-1 etc (4). SP-A and SP-D are hydrophilic 
proteins synthesized and secreted independent of lamellar bodies (4; 109). SP-A regulates 
surfactant secretion (138) and both SP-A and SP-D support alveolar immune defense (142). SP-
B and SP-C are important for the dynamic properties of the pulmonary surfactant. Mice deficient 
of SP-B expression die as neonates because of respiratory failure (24). The mutation of SP-C is 
associated with interstitial lung disease (16).      
1.1.3 Alveolar epithelial cell differentiation 
	

The differentiation of AEC II and AEC I have crucial meanings for the normal lung function. In 
the pseudoglandular stage, some columnar epithelial cells begin to differentiate into ciliated cells 
with the expression of -tubulin IV (100), and some other cells transform into shorter columnar 
cells containing large intracellular glycogen pools (17). These cells remain undifferentiated until 
the canalicular stage, when some of the distal epithelial cells become more cuboidal AEC II and 
begin to synthesize and secrete surfactant. AEC II have less glycogen pools and are 
characterized by the appearance of lamellar bodies (74). Soon after that, the overlying AEC II are 
induced to flatten and differentiate into AEC I.  
Many transcription factors, including thyroid transcription factor-1 (TTF-1), hepatocyte nuclear 
factor (HNF)-3 and HNF-3/forkhead homologue-4 (HFH-4) have indispensable roles on the 
epithelial cell proliferation and differentiation. TTF-1, also known as Nkx2.1, is detected as early 
as E8-E8.5 in mouse endodermal cells and is identified as the earliest known marker of the lung. 
TTF-1 regulates the expression of all the surfactant protein genes, including SP-A, B, C and D. 
Mice deficient of TTF-1 have abnormal lungs which fail to express all the surfactant proteins and 
have significantly reduced collagen type IV and integrins (80).  
HFH-4 is expressed in the epithelium during fetal lung development, and in basal and ciliated 
epithelial cells in the adult lung (129). HFH-4 induces the expression of -tubulin IV in the 
pseudoglandular stage, and promotes the differentiation of ciliated epithelial cells.  
HNF-3 is highly expressed in ciliated and columnar bronchial epithelial cells and AEC II 
during development. HNF-3 induces various lung epithelially restricted genes, including TTF-1 
(46), SP-B (10) and CCSP (113; 114), in association with the differentiation of lung epithelial 
cells, including AEC II and Clara cells.  
Other transcription factors, such as GATA-5, GATA-6, and Fox proteins are also important for 
the cell differentiation in the lung (70). The expression of these transcription factors decreases 
with the progression of development and is only restricted in subsets of Clara cells and AEC II at 
the late stage of development. 
1.1.4 Epithelial-mesenchymal interactions 
The interactive signaling between epithelial and mesenchymal cells is important for normal 
growth, morphogenesis, and cell differentiation in the developing lung. Removing the 
mesenchyme from the embryonic lung rudiment impairs the branching morphogenesis (35; 118). 
Lung mesenchyme has the capability to induce branching morphogenesis in non-lung epithelium 
such as salivary gland (57) and embryonic trachea, whose mesenchyme has been removed (2; 
137). However, non-lung mesenchyme was only able to induce a bud in gut endoderm and these 
buds had no further branching (137). Besides its function in determining the epithelial patterning, 




 The mesenchymal regulation of epithelium is mediated by many growth factors. These 
growth factors are precisely regulated in a temporal and spatial manner during fetal lung 
development. Fibroblast growth factors (FGFs) and their receptors are among the best 
characterized growth factors. They have crucial roles in branching morphogenesis, cell 
proliferation, differentiation, and migration (20). FGF10 is located in the mesenchyme around 
distal lung epithelial tips. It binds to the fibroblast growth factor receptor 2b (FGFR2b) on the 
epithelial cells and transmits a signal to induce the initiation of the lung bud (8; 44; 78; 94; 116; 
134). Recombinant FGF10 alone can induce budding in the lung epithelial explants whose 
mesenchyme has been removed (8). Mice deficient of FGF10 or FGFR2b expression have 
severe abnormalities in lung development (28; 78). Both of these two mice show clear absence of 
lung, indicating that FGF10 and its receptors are crucial for the initiation of lung development. The 
expression of FGF10 and bud formation are regulated by retinoid acid as shown by the evidence 
that antagonist of retinoid acid completely prevents the formation of lung buds from foregut 
explants (29). Retinoid acid accelerates the development of the alveolar tree and promotes the 
expression of surfactant proteins and enzymes for the synthesis of surfactant lipids (68).   
On the other hand, the pulmonary epithelial cells also influence mesenchymal and vascular 
cell proliferation and differentiation (100). The epithelial cells express and secrete vascular 
endothelial growth factors (VEGF). VEGF binds to its receptors, flk and flt in the progenitor cells 
of the mesenchyme, and at least in part, regulates pulmonary vasculogenesis (148). Similarly, 
Platelet-derived growth factor (PDGF), which is expressed in the epithelial cells, stimulates the 
differentiation and proliferation of myofibroblastes in the developing lung (12). Sonic Hedgehog 
(Shh) is a growth factor expressed in the developing epithelium, most abundantly in terminal 
buds. Its receptor Patched-1 (Ptc) is located in the mesenchymal cells. The interaction between 
Shh and Ptc is required for lung bud formation (7; 64; 131). Overexpression of Shh in AEC II with 
a surfactant protein C (SP-C) promoter disturbs the formation of alveoli by increasing the 
proliferation of mesenchymal cells, but not epithelial cells (7).  
Other growth factors, such as transforming growth factors (TGF-) and epidermal growth 
factor (EGF) are also involved in the epithelial-mesenchymal interactions and play essential roles 
in lung development (55).  
1.1.5 Extracellular matrix proteins 
Besides growth factors and transcriptional factors, extracellular matrix proteins play an 
important role in fetal lung development (14; 45; 108). The extracellular matrix proteins include 
intergrins, fibronectins, laminins, proteoglycans, and cadherins. Laminin is a glycoprotein which 
promotes the lung branching morphogenesis. Anti-laminin antibodies significantly reduce 
epithelial cell proliferation and the lung branching formation in fetal lung explant culture (115).  

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Integrins and fibronectins are essential for cell-cell and cell-extracellular matrix interactions. 
Fibronectins promotes branching morphogenesis and regulates the symmetry of the branching in 
cultured embryonic lung explants (108). Integrins and Cadherins are calcium-dependent cell 
surface glycoproteins responsible for cell-cell adhesion. The ligands of integrins include 
fibronectins, laminins and collagens. The binding of integrins to their ligands is crucial to regulate 
the cell proliferation, differentiation and migration, and to maintain the cell polarity during the 
development (120). Cadherins have several subtypes which are expressed in a spatial and 
temporal manner during fetal lung development. E-cadherins is expressed in epithelial cells. N-
candherin is located in neural and muscle cells. VE-cadherin is present in the endothelial cells. 
These cadherins are responsible for the epithelial cell adhesion, thereby promoting the sheet and 
tube formation during branching morphogenesis (73).  
1.2  Pleiotrophin  
1.2.1 Introduction to Pleiotrophin  
 Pleiotrophin (PTN) is an 18 kDa heparin-binding cytokine and shares 50% sequence 
homology with midkine (76). PTN has two beta-sheet domains that bind to heparin and 
extracellular matrix with high affinity (77). The amino acid sequence of PTN is highly conserved 
among different organisms (63). 
PTN was first identified as a growth factor from bovine uterus (77) and as a neurite 
outgrowth promoting factor in the neonatal rat brain (106). In comparison with midkine, which is 
regulated by retinoid acid (51), PTN does not respond to retinoid acid but could be upregulated by 
PDGF in primary hepatic stellate cells (5). The mRNA expression of PTN is significantly 
upregulated in some organs in midkine deficient mice, suggesting that PTN and midkine have 
functional redundancy (40). In fact, PTN and midkine do share multiple functions. They both 
regulate the neurite outgrowth, play important role in neural development and cancer 
development, enhance the proliferation, migration, inhibit the apoptosis of various cells, and have 
important roles in epithelial-mesenchymal interactions during organogenesis (50; 87).    
1.2.2 The expression and multiple roles of Pleiotrophin 
PTN is expressed in a temporal and cell-type-specific manner in order to precisely restrict its 
functional activities at the right time and the right site. The expression level of PTN is regulated 
during development. During the mouse embryogenesis, PTN is highly expressed in central and 
peripheral nervous systems, in organs undergoing branching morphogenesis (including salivary 
gland, lung and kidney), digestive and skeletal systems, sense organ and facial processes and 
limbs (81). The expression of PTN is detected as early as embryonic day 9 and peaks in the late 
stage of embryogenesis (shortly after birth) (63; 132). PTN is mainly located in the basement 
membrane of the developing epithelium and in mesenchymal tissues undergoing remodeling, 
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suggesting that it may regulate cell differentiation and play an important role in mesenchymal-
epithelial interactions. In the adult stage, PTN expression is mainly restricted in central nervous 
system (63; 89).  
PTN is highly expressed in the fetal bone cartilage and plays an important role in the bone 
formation and remodeling (127). During the early stage of osteogenic differentiation, PTN is 
synthesized by osteocytes and located at sites of new bone formation (47; 127). Exogenous PTN, 
but not midkine, promotes the chondrogenesis in micromass culture of chicken limb bud 
mesenchymal cells (32). As a growth factor that stimulates the proliferation and differentiation of 
osteoblastic MC3T3-EL cells, PTN promotes the bone morphogenetic protein (BMP)-induced 
osteogenesis at a high concentration. However, PTN has an opposite effect at a low 
concentration (62; 112). Targeted overexpression of PTN in mice promotes the bone growth and 
maturation during the early stage of bone development. However, the effect is diminished with 
advanced age and the generated bones are more brittle compared to the wild type (62).   
 PTN plays an important role in kidney development. The lung and kidney development 
involves repeated branching morphogenesis and prominent interactions between mesenchyme 
and epithelium. In the embryonic kidney, PTN is present in the basement membrane surrounding 
the developing ureteric bud. Recombinant human PTN increases the branching morphogenesis 
of cultured uteric bud in the presence of glial cell-derived neutrophoic factor (GDNF) (110). In the 
absence of GDNF, PTN still has the ability to induce the branching morphogenesis of uteric cells 
(110). These studies suggest that PTN is one of the key modulators of branching morphogenesis 
in kidney and maybe in other organisms.  
PTN is up-regulated in the injured rat brain cells and plays an role in new tissue formation 
during the recovery from injury (146). After ischemia exposure, dramatically higher PTN levels 
have been observed in macrophages, endothelial cells and astrocytes in the mouse brain, 
especially in the areas with high neovasculogenesis activity, suggesting that PTN may have an 
important role in the neurovascular formation during development. PTN upregulation is also 
observed in dermis after an incisional wound in rat skin (30). Additionally, local delivery of PTN in 
the dog fibrin glue after angioplasty injury significantly increases the rates of re-endothelialization. 
This effect is mainly due to the stimulation of endothelial cell angiogenesis and promotion of 
smooth muscle cell proliferation (15). All these studies suggest that PTN plays essential roles in 
injury repair by promoting tissue regeneration, cell proliferation and differentiation.   
The PTN level is much lower in the adult tissue than that in the fetal tissue. However, PTN is 
overexpressed in a number of cancers, such as human breast cancer (37; 107; 136), melanocytic 
tumor (117; 144), and glioblastoma (65; 85; 102; 149). As a heparin-binding cytokine, PTN acts 
as a growth factor to promote cell growth in cells transformed by the v-sis oncogene (77). The 
function of PTN in tumor angiogenesis has been addressed to some extent. SW-13 cells 
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transformed by PTN amino acid residues exhibit a much higher growth rate and higher density of 
microvessels (150). The nude mice injected with PTN transformed NIH 3T3 cells have a higher 
degree of tumor angiogenesis (22). This effect could be blocked by a dominant negative PTN 
(151). PTN also increases the endothelial cell proliferation and tube formation, suggesting an 
important role of PTN as an angiogenic factor during the tumor formation (146). These studies 
strongly suggest that PTN is a potential target for cancer therapy. Elucidating the function and 
regulatory pathway of PTN may contribute to the establishment of a new cancer treatment 
method. 
PTN also functions as a mitogen for endothelial cells (30; 146), epithelial cells and different 
fibroblast cell lines (77). The function of PTN can be extended to some other aspects, such as 
regulating the long-term potentiation by controlling the neurite cell outgrowth (3).  
1.2.3 PTN regulatory pathways 
PTN signals through three cell surface receptors, syndecan-3, anaplastic lymphoma kinase 
(ALK) and protein tyrosine phosphatase receptor (RPTP/) (87).  
Syndecan-3 belongs to the syndecan family and is a transmembrane protein. Its extracellular 
domain contains 3 glycosaminoglycan attachment sites (21). The binding of PTN with syndecan-3 
induces neurite outgrowth of embryonic neurons (105). Heparitinase, which cleaves heparin 
sulfate chain and disrupts the binding of PTN, inhibits PTN-induced neurite outgrowth. Anit-
syndecan-3 antibodies have a similar effect. Additionally, overexpression of syndecan-3 in N18 
neuroblastoma cells significantly increases the PTN-induced neurite outgrowth. The 
PTN/syndecan-3 pathway is possibly mediated by the c-Src which binds to the intracellulcar 
domain of syndecan-3 and subsequently alters the activity of cortactin (53).   
ALK is a receptor tyrosine kinase highly expressed in the developing nervous systems and 
some tumor cells (48; 82). It shows a similar expression pattern as PTN in different cell lines 
(125).  Upon the binding with PTN, ALK phosphorylates Ras protein or Akt, and thus activates the 
Ras-MAPK or the PI3K-Akt signaling pathway. This sequentially, stimulates cell proliferation and 
mitogenesis, and inhibits apoptosis (102; 125). However   a recent study has shown that ALK 
does not directly bind with PTN, but is one of the substrates of RPTP/ (99).  
RPTP/ is a transmembrane tyrosine phosphatase, which is composed of a cytosoplasmic 
portion carrying protein tyrosine phosphatase activity, a transmembrane region, and an 
extracellular domain containing chondroitin sulfate for ligand binding (38). The extracellular part of 
RPTP/ also possesses a carbonic anhydrase-like domain, a fibronectin III-like domain, and a 
glycine-serine rich domain (38). These domains interact with the adhesion molecules and 
mediate the cell-cell adhesion. PTN is identified as the first natural ligand for the transmembrane 
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tyrosine phosphatase receptors. It binds to the chondroitin sulfate portion of RPTP/ with high 
affinity (69).  
In the absence of PTN, -catenin is associated with E-cadherin. In U373-MG glioblastoma 
cells, the binding of PTN with RPTP/ results in the dimerization and inactivation of the receptor 
and thus significantly increases the tyrosine phosphorylation of -catenin (75; 97).  
Phosphorylated -catenin rapidly dissociates from E-cadherin and accumulates in the cytoplasm. 
The disassociation of -catenin from E-cadherin disrupts the cell-cell adhesion and possibly 
promotes the cell migration. Since -catenin is the central component of Wnt signaling pathway, it 
may be a link between PTN and Wnt signaling pathways. However, how these two pathways are 
associated and whether PTN/ RPTP/ pathway has a role in fetal lung development are 
unknown.   
Other downstream targets of the PTN/RPTP/ include -adducin (92; 93). Recently, the Src 
family member, Fyn has been identified as another substrate of the PTN/RPTP/ signaling 
pathway (91). RPTP/ is broadly expressed in almost all of human breast cancer cells lines, and 
it plays an important role in the adhesion and migration of tumor cells (98). Since the PTN 
pathway through ALK is also mediated through RPTP/, the signal through RPTP/ may be the 
main regulatory pathway for PTN to regulate cell growth, proliferation, migration, and 
mesenchymal-epithelial transition (97).  
1.2.4 PTN knockout mouse 
 At least two groups of PTN knockout mice have been generated to investigate the 
function of PTN. PTN deficient mice are anatomically normal. However, these mice exhibit 
enhanced hippocampal long-term potentiation (3). Deficiency of PTN results in increased 
proliferation rate of neuronal stem cells in the adult mouse cerebral cortex (41). This is consistent 
with the observation that exogenous PTN reduces the neuronal stem cell proliferation through 
inhibiting the expression of FGF-2 and promotes the cell differentiation (41). 
Similarly, midkine knockout mice do not have significant abnormalities (88). However, it 
shows deficiency in memory due to decreased expression of calretinin in the hippocampus of 
infant mice (88). Additionally, midkine knockout mice result in decreased neutrophil infiltration 
after ischemic renal injury (111). Interestingly, midkine knockout mice have increased PTN 
expression in many organs, including eye, heart, bladder etc., suggesting they may have 
redundant roles (40).  
The few abnormalities shown by PTN or midkine knockout mice seem to be inconsistent with 
their crucial roles in the proliferation, differentiation and migration of various cells. This may be 
partly due to the functional redundancy between PTN and midkine. Lack of PTN expression might 
somehow be compensated by midkine. To test this possibility, some research groups have 
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produced PTN and midkine double knockout mice. These mice have reduced expression of beta-
tectorin and serious auditory deficits (154). Additionally, they have significantly reduced 
reproduction abilities and exhibit infertility in most female mice (86).   
 Transgenic mice overexpressing PTN show abnormalities in brain and bone formation 
and remodeling. PTN overexpressing mice are morphologically normal, but have attenuated 
hippocampal long term potential (96). Specifically overexpressing PTN in osteoclasts under the 
control of human osteocalcin promoter increases bone mass in female mice, but not male mice 
(39; 71). These mice also have advanced bone growth during the early developing stage, 
damaged fracture healing, and delayed callus formation (62).  
PTN also has a high expression during the late stages of fetal lung development. However, 
its role in the lung development has never been studied. Additionally, PTN expression in the lung 
is not dependent on midkine expression (40), suggesting that PTN and midkine may have distinct 
roles in the lung. 
1.3 Wnt signaling pathway 
Wnt is a family of growth factors which play important roles in cell proliferation and cell fate 
determination. Wnt has as many as 19 isoforms which bind to frizzled receptors (fzs) and trigger 
at least three intracellular signaling pathways. One of the most important pathways of Wnt 
signaling is the canonical signaling pathway through -catenin. Wnt regulates lung 
morphogenesis through the canonical -catenin/LEF-TCF pathway (33; 95; 141). The binding of 
Wnt to frizzleds inhibits the activity of glycogen synthase kinase (GSK-3) and thus stabilizes -
catenin in the cytoplasm. -catenin accumulates in the cytoplasm and translocates into the 
nucleus, where it binds to TCF/LEF transcription factors to stimulate the transcription of its 
downstream genes, such as N-myc, bone morphogenetic protein 4 (Bmp4), FGF etc (121). 
Current studies of Wnt signaling in the developing lung reveal essential roles of Wnt in normal 
lung development.   
1.3.1 Wnt and -catenin expression during fetal lung development 
 The expression of Wnts and -catenin are precisely regulated during fetal lung 
development. In situ hybridization reveals that Wnt2 is highly expressed in the fetal lung, and its 
expression is restricted to mesenchymal cells (60). In fetal E12.5 to E16.5 mouse lung, Wnt11 
expression is observed in epithelial and mesenchymal cells (56), while Wnt7b is only localized in 
distal and proximal bronchial epithelial cells (135). Wnt5a expression is barely detectable in E12 
mouse lung, and reached a high level in E16 in both epithelial and mesenchymal cells. In E18, 
Wnt5a is mainly localized in airway epithelial cells (61). Wnt3a expression is mainly in AEC II and 
some ciliated airway epithelial cells in the adult human lung (54).  
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 -catenin is expressed in the airway and alveolar epithelial cells during fetal lung 
development. -catenin nuclear expression is especially high in pre-alveolar acini budding from 
respiratory airways (33). From E14.5 to E17.5, cytoplasmic and nuclear expression of -catenin is 
also found in the primordial and alveolar epithelial cells, and adjacent mesenchymal cells, 
indicating that the -catenin signaling may be activated in these cells (33). The cytoplasmic and 
nuclear -catenin level decreases in the mesenchyme after E13.5 (128). TCF and LEF have very 
similar expression pattern as -catenin during fetal lung development (128). TCF1 protein is 
present in both epithelial and surrounding mesenchymal cells from E10.5 to E17.5. LEF1 protein 
expression is high in adjacent mesenchyme but low in proximal epithelium. TCF3 and TCF4 
protein are almost expressed in all kinds of cells, including proximal and distal alveolar epithelial 
cells, and mesenchymal cells from E11.5 to E17.5 (128).     
 The mesenchymal localization of Wnt ligands and epithelial localization of -catenin 
suggest the possible role of Wnt signaling in epithelial-mesenchymal interactions, which is crucial 
for normal lung morphogenesis, growth, and cell fate determination. Since -catenin nuclear 
localization is mainly observed in developing epithelial cells, Wnt canonical signaling may 
mediate the epithelial proliferation or differentiation.  
1.3.2 Wnt signaling in lung morphogenesis 
 Recently, the transgenic and knockout mice studies have revealed some important roles 
of Wnt signaling on lung morphogenesis. Wnt5a conditional knockout is fatal and results in 
abnormal distal lung morphogenesis, which is characterized by the hypercellular and thicker 
intersaccular walls (61). However, Wnt5a knockout does not affect vascular distribution and 
maturation.  
The lungs from Wnt7b null mice exhibit a smaller and collapsed appearance and fail to 
inflate properly which causes the death of these mice shortly after birth (122). Wnt7b knockout 
lung has other defects, such as hypoplasia, which is shown by extremely thin distal mesenchyme. 
Additionally, smooth muscle -actin (-SMA) expression is abnormal in Wnt7b knockout mice. 
Since smooth muscle cells are differentiated from mesenchymal cells, these studies indicate that 
Wnt7b affects the lung morphogenesis possible through the regulation of mesenchyme cells.  
 Specifically silencing -catenin in the embryonic mesenchyme leads to shortened 
trachea, decreased branching, and reduced peripheral mesenchyme (27). However, the sub-
epithelial mesenchyme is not affected. On the other hand, overexpression of -catenin in alveolar 
type II cells using SP-C promoter destroys the normal lung morphogenesis, arrests the 
differentiation of peripheral airways, and leaves the lung containing mainly conducting airways 
(84).  Consistently, hyperactivating -catenin in epithelial cells of the developing lung causes 
enlarged air space, atypical expression of alveolar type II cells, and epithelial cell dysplasia. This 
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effect is possibly through the downregulation of Foxa2 expression in the epithelium (83). 
However, further work may be required to elucidate the molecular mechanism of this process.  
1.3.3 Wnt signaling in cell differentiation and proliferation 
 The action of Wnt signaling on the lung morphology is mainly achieved by the regulation 
of proliferation, differentiation and apoptosis of the lung cells. The regulation of the lung cell 
proliferation by Wnt signaling is well coupled with cell differentiation. The signals that increase the 
proliferation of progenitor cells normally arrest the further differentiation of these cells. 
 Wnt7b knockout mice did not show abnormal differentiation of some epithelial cells 
including Clara cells, and alveolar type II cells. However, the alveolar type I cell differentiation is 
delayed in Wnt7b knockout mice, suggesting that Wnt7b may be important for the late epithelial 
cell differentiation. Wnt7b knockout significantly reduces the proliferation of mesenchymal cells on 
E12.5 but not on E14.5. However, the proliferation of epithelial cells is not affected (103; 122). 
These results indicate that Wnt7b is a regulator for mesenchymal cell proliferation in the early 
developing lung. Besides that, apoptosis increases significantly in the vascular smooth muscle 
and epithelium following the deprivation of Wnt7b.  
 Interestingly, hyperactivation of -catenin specifically in lung endoderm leads to 
increased amplification of distal lung progenitor cells and lacking of fully differentiated lung cell 
types (90). Activation of -catenin signaling only in epithelial cells causes ectopic differentiation of 
AEC II (83). Additionally, conditional knockout -catenin in mesenchyme increases the 
proliferation of Fgf10 expression in parabronchial smooth muscle cells (PSMC). However, the 
differentiation of this group of cells is not affected (27). All these results indicate that -catenin 
signaling is essential for normal epithelial differentiation. 
Conditional knockout of Wnt5a caused a significant increase in lung cell proliferation without 
interfering with cell differentiation (61).  
1.3.4 Wnt signaling in lung diseases 
 The dysregulation of Wnt signaling in adult lung causes many diseases such as lung 
cancer, fibrosis, and inflammation (101). Hyperactivation of -catenin caused by mutations of -
catenin, adenomatous polyposis coli (APC) and axin in lung epithelium induces lung tumors (83). 
-catenin are highly overexpressed and activated in many lung cancer cells . Drugs targeting 
wnt/-catenin have become a novel therapeutic strategy for cancer. Fibrosis is a crucial process 
during tissue repairing after an injury. Hyperactivation of wnt signaling pathway causes abnormal 
cell proliferation and differentiation during pulmonary fibrosis, and also overexpresses fibrosis 
regulators such as metalloproteinase matrilysin (101). 
 In summary, Wnt is important for cell proliferation and differentiation during fetal lung 
development, although how Wnt proteins regulate the lung development is still not clear. Wnt7b 
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promoter is regulated by TTF-1 (135), a known transcription factor regulating multiple epithelium 
cell differentiation in the developing lung. This finding suggests a possible molecular mechanism 
of TTF-1 in regulating the lung epithelium differentiation.  
1.4 P2X7 receptors and microRNAs 
Purinergic receptors are composed of P2X receptors (P2XR) and P2Y receptors (P2YR). 
P2XR are expressed in many cells including neuron, glia, bone, epithelial and endothelial cells 
(104). P2XRs are plasma membrane ligand-gated ion channels activated by purine nucleotides 
including ATP, while P2YRs are G-protein-coupled receptors which mediate slow responses 
through G-proteins (1). In mammalian cells, P2XRs are encoded by 7 genes which either 
comprise seven functional homomeric assemblies (P2X1-P2X7) or form functional heteromeric 
assemblies (P2X 1/2,1/4,1/5,2/3,2/6,4/6,4/7 etc) (139). Generally, P2XR assemblies contain three 
glycosylated subunits, and each has two transmembrane-spanning domains. These six 
transmembrane-spanning domains are closely associated to form the ion channel (139). The 
binding of ATP causes P2XR to open within milliseconds and stimulate cell depolarization by an 
influx of cationic ions, including Na+, K+, Ca2+ ions, and, in some cases, large ions such as Cl- 
ions. The moderate influx of Ca2+ activates a cascade of intracellular signaling molecules, which 
subsequently regulates a series of cellular processes. However, high ATP doses and sustained 
stimulation of P2XR may result in irreversible cell damage and lead to necrosis or apoptosis.  
P2X7R is quite different from other P2XRs. Structurally it has an unusually long C-terminus. It 
can form a large non-selective pore permeable to larger molecular weight species (123). The 
activation of P2X7R needs at least 10-fold higher concentration of ATP. This high concentration 
of ATP is normally achieved during a massive lysis of host cells or pathogen defense. 3’-O-(4-
benzoyl) benzoylATP (BzATP), which has around 10-fold more activities than ATP, is the most 
potent known agonist for P2X7R. High doses of BzATP and sustained stimulations of P2X7R also 
lead to membrane blebbing and programmed cell death (130).  
P2X7R was initially identified in immune systems as an ion-channel receptor which is non-
selectively permeable to large molecules and mediates the programmed cell death (36; 126). 
Stimulation of P2X7R leads to the secretion of IL-1beta from macrophages, and consequently 
initiates the pro-inflammatory response (23; 67). P2X7R is involved in pathological conditions, 
such as pain, inflammation, apoptosis, neurodegenerative conditions, and Alzheimer disease (9; 
42). Recently, P2X7R has been used as a therapeutic target for pharmacological intervention.  
MicroRNAs (miRNA) are small non-coding RNAs that can either cleave specific mRNAs or 
inhibit mRNA translation through complementary base pairing (6). MiRNAs naturally exist in 
organisms. They regulate diverse cellular processes such as proliferation, differentiation, 
apoptosis, and exocytosis.  
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The processing of miRNAs includes several steps. MiRNAs are first transcribed as pri-
miRNAs from the genomic DNA. The production of mature miRNA is a two-step process, which 
requires both Drosha and Dicer 33. Drosha is a nuclear RNase III endonuclease. Drosha-DGCR8 
complex (DiGeorge syndrome critical region gene-8) cleaves the pri-miRNA and releases the 
loop structure from the primary transcript to generate the pre-miRNAs (58). The pre-miRNAs are 
~70 nt long and contain a stem-loop structure (59).They contains 2-nt overhangs at their 3’ ends. 
They first bind to Exportin 5-RanGTP, and are exported out of the nucleus. In the cytoplasm, the 
pre-miRNAs are further cleaved by Dicer to yield the mature miRNAs (11; 66; 147).  
The function of miRNAs is mostly through the reduction of their target proteins. miR-150 and 
miR-186 are identified to target P2X7R protein in HeLa and primary human ectocervical-vaginal 
epithelial cells and disrupt P2X7R expression (153). MiR-150 is highly expressed in the tumour 
cells surrounding the proliferation centres in the bone marrow and lymphoid tissues (133). MiR-
150 is also present in mature B and T cells and blocks B cell development by decreasing the 
expression of c-Myb (145; 152). The functions of miR-150 and miR-186 in the lung have not been 
studied yet.  
1.5 Purposes 
Mammalian lung development is a complex biological process which is temporally and 
spatially regulated by growth factors, hormones, and extracellular matrix proteins. Abnormal 
changes of these molecules often lead to impaired lung development and thus pulmonary 
diseases such as pulmonary hypoplasia and neonatal respiratory distress syndrome (43; 143). 
The first part (Chapter 2) of the dissertation research focuses on the DNA Microarray to 
identify genes that are differentially expressed during fetal lung development. Such studies lead 
to the discovery that PTN is highly expressed at the late stage of fetal lung development. Chapter 
3 investigates the role of PTN in fetal lung epithelial cell proliferation and differentiation and its 
regulatory pathway in in vitro cell and organ cultures. Chapter 4 further studies physiological 
functions of PTN in lung development using PTN knockout mice. The secretion of lung surfactant 
into alveolar space is crucial for the preparation for extrautero life. Thus the regulation of 
surfactant secretion is an important aspect of lung development. Chapter 5 examines how 
microRNA-150 regulates surfactant secretion via P2X7R. Finally, chapter 6 deals with a technical 
aspect of real-time PCR, a byproduct derived from this dissertation research.  
PTN is a growth factor differentially expressed during fetal lung development. The elucidation 
of the role of PTN in fetal lung development and its regulatory pathway may offer opportunities in 
the development of new therapeutic strategies and drugs to resolve the disorders associated with 
fetal lung development. Successful differentiation of AEC II and AEC I has crucial functions to 
surfactant secretion during lung development. Insufficient amount of pulmonary surfactant leads 




channel specifically expressed in AEC I, may play an important role in surfactant secretion. 
Elucidation of the regulation of P2X7R will open a new area for developing therapeutic strategies 
to treat lung diseases.  
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GENE EXPRESSION PROFILING IDENTIFIES REGULATOR PATHWAYS INVOLVED IN THE 
LATE STAGE OF RAT FETAL LUNG DEVELOPMENT 
 
2.1 Abstract 
Fetal lung development is a complex biological process that involves temporal and spatial 
regulations of many genes. To understand the molecular mechanisms of this process, we 
investigated gene expression profiles of fetal lungs on gestational days 18, 19, 20, and 21, as well 
as newborn and adult rat lungs. For this analysis, we used an in-house rat DNA microarray 
containing 6,000 known genes and 4,000 expressed sequence tags (ESTs). Of these, 1,512 
genes passed the statistical significance analysis of microarray (SAM) test; an at least twofold 
change was shown for 583 genes (402 known genes and 181 ESTs) between at least two time 
points. K-means cluster analysis revealed seven major expression patterns. In one of the clusters, 
gene expression increased from day 18 to day 20 and then decreased. In this cluster, which 
contained 10 known genes and 5 ESTs, 8 genes are associated with development. These genes 
can be integrated into regulatory pathways, including growth factors, plasma membrane receptors, 
adhesion molecules, intracellular signaling molecules, and transcription factors. Comparing the 
expression changes between adjacent time points, real-time PCR analysis of these 10 genes 
showed an 88% consistency with the microarray data. The mRNA of LIM homeodomain protein 
3a (Lhx3), a transcription factor, was enriched in fetal type II cells. In contrast, pleiotrophin, a 
growth factor, had a much higher expression in fetal lung tissues than in fetal type II cells. 
Immunohistochemistry revealed that Lhx3 was localized in fetal lung epithelial cells and 
pleiotrophin in the mesenchymal cells adjacent to the developing epithelium and blood vessel. 
Using GenMAPP, we identified four regulatory pathways: transforming growth factor- signaling, 
inflammatory response, cell cycle, and G protein signaling. We also identified two metabolic 
pathways: glycolysis-gluconeogenesis and proteasome degradation. Our results may provide new 
insights into the complex regulatory pathways that control fetal lung development. 





Fetal Development of the pulmonary system is a complex and important morphogenetic 
process. The lung is among the last of the fetal organs to mature functionally. Development of this 
complex air-exchange interface can be divided into five stages (6). In the embryonic stage (days 
0–13), the lung originates as an outpouch from the ventral wall in the primitive esophagus and 
grows caudally into the splanchnic mesoderm to form the right and left buds. The terminal buds 
then dichotomously divide until the lung forms a glandlike structure. During the pseudoglandular 
stage (days 13–18), the bronchial buds repeatedly branch into the mesenchymal tissue to form 
the conductive airways of the lung. At this stage, there is little lumen in the epithelial tubes. In the 
canalicular stage (days 18–20), the lung grows considerably, with multiple generations of 
bronchioles. Capillaries are closely arranged with the terminal and respiratory bronchioles. The 
columnar epithelial cells undergo morphological changes to become cuboidal epithelial cells. In 
the saccular stage (day 20 to full term), the terminals of bronchioles become saccular, with the 
formation of alveolar ducts and air sacs. Capillaries bulge into terminal sacs to establish blood-air 
barriers. In the alveolar stage (from full term to adult), the alveolar-capillary barrier becomes 
progressively thinner, with an increasing capacity for gas exchange. The number and size of 
capillaries and alveoli increase markedly. 
Coordinated regulation of signaling molecules and their pathways is required for fetal lung 
development (7, 41, 63, 80). These molecules include, for example, retinoic acid, fibroblast 
growth factors, transforming growth factors (TGF), and sonic hedgehog. Complex interactions 
occur between epithelial, mesenchymal, and extracellular matrix components. Through temporal 
and spatial regulations of these molecules and their interactions, the stem cells proliferate and 
differentiate into  40 distinct cell lineages, resulting in formation of the whole lung tissue. 
DNA microarray has been used for gene expression profiling of pulmonary diseases, 
including lung cancers (3), emphysema (16), and hyperoxia or ventilator-induced lung injury (35, 
53). This approach has been used previously to study mouse fetal lung development (2, 38). 
However, DNA microarray analysis of rat fetal lung development has not been reported. Gene 
expression in response to hypoxia differs among species (19). Our main objective in this study 
was to examine gene expression profiles during the late stage of rat fetal lung development. We 
focused on the late stage of fetal lung development because our research interests involve 
alveolar epithelial cell proliferation and differentiation. We used a DNA microarray representing 
10,000 known rat genes and expressed sequence tags (ESTs) to profile gene expression of fetal 
lungs on gestational days 18, 19, 20, and 21 and newborn and adult rat lungs. Clustering analysis 
identified an important gene cluster involving lung development. Real-time PCR and Western blot 
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confirmed the changes in gene expression of selected genes. Several pathways were also 
identified using GenMAPP and literature review. 
2.3 Materials and Methods 
2.3.1 Microarray slide preparation.  
The DNA microarray slides were prepared in-house using the Pan-Rat 50-mer 10,000K 
oligonucleotide set (MWG Biotech, High Point, NC), which includes 6,221 known rat genes, 3,594 
rat ESTs, and 169 Arabidopsis-negative controls. The oligonucleotides were diluted to 25 µM with 
3x saline-sodium citrate (SSC) and printed on epoxy-coated slides (CEL Associates, Pearland, 
TX) by a microarrayer (OmniGrid 100, GeneMachine, San Carlos, CA). The samples were 
spotted on each slide in triplicate using 16 ChipMaker Micro Spotting Pins (Telechem 
International, Sunnyvale, CA). This resulted in three identical 18 x 18 mm blocks on each slide, 
which allowed us to hybridize six samples on a single slide (Fig.II.1A). The diameter of each spot 
was 120 µm, and the distance between two spots was 180 µm. The printed slides were incubated 
in 65% humidity for 48 h, dried, and kept at room temperature. Slide quality was assessed using 
SYBR Green II staining. No autofluorescence was found when the blank slides were scanned. 
 
 
Fig.II.1. DNA microarray slides and experiment design. A: slides printed in-house with 3 identical 
blocks, each containing 10,000 rat genes, which allowed us to hybridize 6 samples on a single 
slide. B: loop design for microarray hybridization study. Each RNA sample was divided into 2 
parts: one was labeled with Alexa 546 and the other with Alexa 647. Two cDNAs with different 
dyes were paired and hybridized to 1 block. Arrows correspond to hybridizations between 2 RNA 
samples: blunt end labeled green, and arrow end labeled red. Number 4 on the arrow indicates 4 
biological replicate hybridizations. Opposite directions of the 2 arrows represent dye flipping. D18, 




















2.3.2 Isolation of rat fetal lungs. 
We chose six lung tissues, 
DNA microarray experiments:
D20, and D21) and newborn (NB) and adult (AD) lungs. The
Care and Use Committee approved
fetal lungs, timed-pregnant Sprague
uterine horns were exposed
harvested. The isolated lungs were placed in ice
and adult rat lungs were collected from
cells were isolated from fetal or newborn l
(15). The purity and viability
staining and trypan blue exclusion. Adult lungs and alveolar
as previously described (9). Total RNAs were extracted from the lung tissues or cells
Reagent (Molecular Research Center, Cincinnati, OH).
2.3.3 DNA microarray hybridization. 
A loop design was used for our microarray hybridization to compare
expression between two adjacent time points
sequential event, a loop design has some advantages over a reference design. In
design, indirect comparison of adjacent time points
accumulated errors. In a loop design, direct comparison between two adjacent time points
significantly increases the efficiency and accuracy of the experiments.
were performed for each sample (4 biological
adjacent time points). Total RNAs were divided into two aliquots; each (10
transcribed to cDNA using the modified
(Genisphere, Hatfield, PA). The cDNA was purified with Microcom YM
Billerica, MA) and mixed with 2x hybridization buffer
The cDNA concentrations were adjusted to 300 ng/µl. Five microliters of cDNAs
time points were mixed and hybridized to one
42°C. After the unbound cDNAs were washed away with 2x SSC buffer
MO), the slides were further incubated
546) or red (Alexa 647) dye for 2
(ScanArray Express, Perkin Elmer, Boston,
adjusted so that 5% of the spots were saturate
2.3.4 Microarray data analysis. 
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 (Fig.II.1B). Because fetal lung development is a 
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The scanned images were first inspected visually to uncover
macroartifacts. Because of weak or bad
biological replications X 2 dye swap) 
obtained from the scanned slides
were normalized by LOWESS normalization using RealSpot software,
our laboratory (10). A quality index
background ratio, was exported from RealSpot. The mean QI values were calculated
Any spots with mean QI < 1 were filtered. One
statistical test was applied to the remaining genes using a cutoff 
(http://www.stat.stanford.edu/
filtered using a fold change cutoff
a coefficient of variation cutoff value of
clustering using Cluster and TreeView (
the expression patterns were analyzed and
Gene Ontology (http://www.geneontology.org/
GenMAPP (http://www.genmapp.org/
the context of biological pathways. The log
adult (NB/AD) were used for comparison of prenatal, postnatal,
2.3.5 Real-time PCR.  
The gene verification was carried out by real
the DNA microarray hybridization.
Austin, TX) to remove DNA contamination and reverse
hexamers and Maloney's murine leukemia virus
primers were designed using Primer
length of each primer was 20
time PCR was performed on an ABI 7500 system using SYBR
Valencia, CA), as previously described
included a data acquisition step at 2
After the amplification, a melt
standard curve was constructed on the basis of serial dilutions
and corresponding threshold
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Table.II.1. Real-time PCR primers  
GenBank ID 
Gene 
Name Up Down 
AF370446 Lhx3 GGAACCACTGGATTAGTGACTACCA GTCCAAGATGTGCTGGTCACAT 
AY045577 Epha3 CCCATCAAGTTCTCCGAGAAGTT GACACTTCCAATGCAGGTTGTG 
NM_013414 Bgp GACAAGTCCCACACAGCAACTC TGGACATGAAGGCTTTGTCAGA 
NM_017066 Ptn ATACCAGCAGCAACGTCGAAA GCACACACTCCATTGCCATT 
NM_019161 Cdh22 GTGCTGGCTTTGCTGATTCTC AGCTCGTCGATCAGGAAGATG 
NM_019286 Adh3 CGGTTAGTGGATCCCTGTTCA TATCACCTGGTTTCACACAAGTCA 
NM_024141 Thox2 CCAGGGATGACCAAGAATGTG TGGTCTCAAGTGACGGTAACAGA 
NM_031043 Gyg ACCAAGCCATGGAATTACACGTA CCACCACAGGTTCAGAAACTCTG 
NM_053744 Dlk1 GTGAAGAACCATGGCAGTGTGT GACAGTCCTTTCCAGAGAATCCA 




Primers were designed by Primer Express software. Each primer was 20–25 bp long with a 
melting temperature of 58–60°C. All genes sequences were from Rattus norvegicus. Lhx3, LIM 
homeodomain protein 3a; EphA3, ephrin A3; Bgp, osteocalcin; Ptn, pleiotrophin; Cdh 22, 
cadherin 22; Adh3, alcohol dehydrogenase 3; Thox2, NADH/NADH thyroid oxidase; Gyg, 
glycogenin; Dlk1, delta-like homolog Drosophila; Nelf, nasal embryonic luteinizing hormone-
releasing hormone factor. 
 
2.3.6 Immunohistochemistry. 
The isolated fetal lungs were briefly washed with deionized water and immediately fixed with 
4% formaldehyde in PBS. After 24 h of incubation, the lungs were rinsed with PBS, dehydrated in 
graded alcohol and xylene, and embedded in paraffin (60°C). Paraffin-embedded lungs were 
sectioned (4 µm) and placed on polylysine-coated glass slides. The lung sections were boiled for 
30 min in 20 mM citrate buffer (pH 6.0) for antigen retrieval, which exposed the antigens masked 
during the sample fixation process. The sections were permeabilized with 0.3% Triton X-100 in 
PBS for 15 min and blocked with 10% fetal bovine serum in PBS for 30 min and then incubated in 
goat anti-pleiotrophin (Ptn) or rabbit anti-LIM homeodomain protein 3a (Lhx3) antibodies (1:100 
dilution; Abcam, Cambridge, MA) overnight at 4°C. The slides were washed and then incubated 
with biotinylated anti-goat or anti-rabbit antibody for 30 min and for an additional 30 min with ABC 
reagent (Vector Laboratories, Burlingame, CA). The slides were developed with 3,3'-

diaminobenzidine until the desired
antifade medium (5% n-propyl gallate and 80% glycerol in PBS) and examined
Eclipse E600 microscope.  
2.3.7 Western blot. 
The lung tissues were homogenized in lysis buffer (10 mM Tris·HCl,
100, 1 mM EDTA, 1 mM phenylmethylsulfonyl
leupeptin) on ice. Protein concentration was determined using the D
Hercules, CA). Total proteins were separated
nitrocellulose membrane. The blot was stained by Ponceau S to check transfer efficiency.
membrane was blocked with 5% dry milk in Tris
saline containing 0.05% Tween
mouse anti--actin antibody (1:1,000 dilution; Bio
washed again and incubated with
(1:2,000 dilution) for 1 h. Finally, the membrane was developed
chemiluminescence reagents (Amersham Biosciences,
film.  
2.4 Results 
2.4.1 DNA microarray data analysis.
To identify the genes that changed during the late stage of
performed DNA microarray (10,000
AD) were arranged for hybridization using a loop design (Fig.II.1B).
hybridizations (4 biological replications
and 40 were used for further data analysis [D18/AD (n = 6)
D21/D20 (n = 8), NB/D21 (n = 5), and
normalization. Bad or weak spots were removed by filtration using a cutoff
genes, 1,512 (928 known genes and
false discovery rate (q value) of <0.01. Additional criteria
known genes and 181 ESTs):
names, gene identifications, average log
terms are listed in supplemental Table 1 (see online version of this article).
dataset is available at GEO database (
2.4.2 Cluster analysis and major functional categories.
We used K-means cluster analysis to cluster the 583 above
nodes. We found that the best approach was to group the genes into seven clusters on the basis 

 staining appeared. Finally, the slides were mounted with 
 pH 7.5, 1% Triton X
 fluoride, 10 µg/ml aprotinin, and 10 µg/ml 
C protein
 assay kit (Bio
 by 10% SDS-PAGE and then transferred onto a 
-buffered saline for 1 h, washed with Tris
 20, and incubated with goat anti-Ptn antibody (1:1,000 dilution)
-Rad) overnight at 4°C. The membrane was 
 horseradish peroxidase-conjugated anti-goat or anti
 Piscataway, NJ) and exposed to X
  
 fetal lung development, we 
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 QI < 1. Of these 10,000 
 584 ESTs) passed the one-class statistical SAM test using a
 were used to identify 583 genes (402 
 a fold change of 2 and a coefficient of variation of <0.5.
2[(ratio)s],
 Gene Ontology (GO) identifications, and GO 
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of their expression patterns (Fig.II.2A). Of the 583 genes, 272 were annotated by GO 
(http://www.geneontology.org). The percentage of major functions for each cluster was calculated 































Fig.II.2. Tree view and functional categories for clustered genes. A: K-means clustering analysis 
on 583 genes, which significantly changed between  2 time points (P < 0.01, fold change  2, 
coefficient of variation  0.5) using cluster and tree view. Genes were clustered into 7 clusters. 
Each row corresponds to 1 gene, and each column corresponds to 1 log2(ratio). Numbers in 
parentheses adjacent to ratios represent number of hybridizations used for data analysis. Red, 
upregulation; green, downregulation; black, no change. Brightness of the color represents the 
value of the ratio. B: expression patterns and functional analysis of each cluster. The 7 clusters 
identified from K-means clustering analysis were plotted as log2 (ratio) vs. time. Distribution of 
major functional categories for biological process terms are shown in pie charts. The log2(ratio) is 
each time point vs. adult. Values are means ± SD. 
 
2.4.3 GenMAPP. 
To identify signaling pathways, metabolic pathways, and other functional groups that may be 
involved in fetal lung development, we used GenMAPP to visualize the changes in gene 
expression. The log2(D18/AD) and log2(NB/AD) were chosen to represent prenatal, postnatal, 
and adult lungs. The data sets were imported into GenMAPP. Four major regulatory pathways 
































































































































pathways (glycolysis-glycogenesis and proteasome degradation) were identified (data not 
shown).  
2.4.4 Real-time PCR validation. 
We next focused on cluster 5, the "differentiation cluster," for further studies. Gene 
expression in this cluster increased in the canalicular stage (D18–D20) and then decreased (D20 
to AD). This group consists of 5 ESTs and 10 known genes. Among the 10 known genes, 8 were 
directly or indirectly involved in development or cell differentiation. Table.II.2 shows the major 
functions and the cellular locations of these 10 known genes.  
Table.II.2. Cluster 5 genes and their functions 
Name Location Major Functions Protein Localization 
Lhx3 Neuron, 
pituitary 
Homeobox gene family; homeodomain 
transcription factor; important in cell migration and 
development 
Nucleus 
EphA3 Neuron Involved in Wnt-Frizzled signaling, which controls 
various aspects of early development; 






Guide for migration of olfactory axon and 
gonadotropin-releasing hormone neurons; cell 
development 
Cytoplasm 
Bgp Bone Bone-specific gene Extracellular matrix 
Ptn Bone Growth factor activity; heparin binding; regulation 




Integral to membrane; brain development; Ca2+-
dependent cell-cell adhesion 
Membrane 
Adh3 Mixed tissue Alcohol oxidation; stimulation of retinoic acid 
synthesis; stimulation of cell growth 
Cytoplasm 
Dlk1 Mixed tissue Membrane-spanning protein containing 6 
epidermal growth factor-like repeat motifs, 
regulating growth and differentiation through cell-
cell interaction 
Membrane 
Thox2 Mixed tissue NAD(P)H oxidase activity Membrane 






We attempted to verify the microarray data from the 10 known genes in cluster 5 using 
absolute quantitative real-time PCR. The copy number was obtained from the standard curve 
constructed from the purified PCR products and normalized to 18S rRNA. The expression levels 
of these genes are shown in Fig.II.3A. Delta-like homolog Drosophila 1 (Dlk1) had the highest 
expression, followed by glycogenin, Ptn, and alcohol dehydrogenase-3 (Adh3). In contrast, 
expression of Lhx3 was the lowest. The log2(ratio) between adjacent
 time points was calculated 
and compared with the microarray data. As shown in Fig.II.3B, 88% of the log2(ratios) from real-
time PCR were consistent with the microarray data, even though absolute changes varied. In 
general, fold change of real-time PCR was greater than that of the microarray, probably because 
of the difference between the two methods (solid-state vs. solution hybridization), which makes 









































Fig.II.3. mRNA expression of cluster 5 genes during fetal lung development: comparison of 
microarray with real-time PCR. Total RNA was extracted from fetal lungs on gestational days 18–
21 and from newborn and adult lungs and reversed transcribed to cDNA. mRNA levels were 
determined by real-time PCR, and data were normalized to 18S rRNA. A: relative mRNA 
expression levels of cluster 5 genes. B: comparison of microarray and real-time PCR: D18/D19 
(1), D19/D20 (2), D20/D21 (3), D21/NB (4), NB/AD (5), and D18/AD (6). Values are means ± SE; 
n = 8 (4 animal groups and each assay performed in duplicate) for microarray and real-time PCR. 
 
2.4.5 mRNA expression of Ptn and Lhx3 in fetal lung cells. 
The mRNA levels of Ptn and Lhx3 in the isolated lung cells were determined using real-time PCR. 
Ptn was highly expressed in fetal lung tissues (D18, D19, D20, D21, and NB), but there was 
essentially no expression in adult lung tissues (AD; Fig.II.4A). Ptn mRNA expression in isolated 
alveolar epithelial type II cells from fetal lungs on days 18 and 19 and newborn and adult lungs 
was negligible. Also the mRNA of Ptn was not found in alveolar epithelial type I cells or 
macrophages isolated from adult lungs. On the other hand, mRNA expression of Lhx3 was high 

































































































in type II cells isolated from fetal lungs on days 18 and 19 and adult lungs and low in type I cells 
isolated from adult lungs and in macrophages. Relatively low expression of Lhx3 was observed in 
fetal and adult lung tissues, indicating its specific expression in fetal type II cells. 
 
Fig.II.4. Real-time PCR analysis of pleiotrophin (Ptn) and LIM homeodomain protein 3a (Lhx3) in 
fetal lung cells. Total RNA was extracted from lung tissues and reverse transcribed to cDNA. 
mRNA abundance of Ptn (A) and Lhx3 (B) was determined by real-time PCR in adult alveolar 
type I cells (TI-AD), adult alveolar type II cells (TII-AD), fetal epithelial type II cells on gestational 
days 18–21 (TII-D18 to TII-D21), newborn alveolar type II cells (TII-NB), adult microphages (M-
AD), fetal lung tissue on gestational days 18–21, and newborn and adult lung tissue. Values are 
means ± SE; n = 8 (4 biological preparations, each assay performed in duplicate). *P < 0.05 vs. 
AD or TII-AD. 
 
2.4.6 Ptn and Lhx3 protein expression.  




































































We used Western blot to quantify Ptn protein expression in fetal lung tissues. Ptn protein was 
significantly upregulated in fetal lungs on days 20 and 21 and newborn lungs compared with fetal 
lungs on days 18 and 19. However, very little Ptn protein was found in adult lungs (Fig.II.5A).  
To determine the cellular localization of Ptn and Lhx3 proteins in fetal lungs, we performed 
immunohistochemistry using the ABC reagent. Lhx3 was primarily expressed in the columnar 
cells of the developing airways. The positive signal was located in the nucleus and showed a 
purplelike color on counterstaining with hematoxylin (Fig.II.5B). Ptn was located in the 
mesenchyme adjacent to the developing epithelium and endothelium (Fig.II.5B). Some staining 
was noted on the endothelial cells. No positive staining was found in the negative control without 
primary antibodies (data not shown). 
 
 
Fig.II.5. Protein expression and cellular location of Lhx3 and Ptn. A: Western blot analysis of Ptn 
in fetal lungs on gestational days 18–21 and in newborn and adult lungs. -Actin was used as 












and d) antibodies. Panels c and d are enlarged fields enclosed in boxes of panels a and b, 
respectively. Lhx3 was located in the nucleus of columnar epithelial cells (arrow). Endothelial 
cells (*) and mesenchymal cells (arrow) around the epithelium and blood vessels stained positive 




The gene expression profiles of fetal lung development in mice have been reported 
elsewhere (2, 38). However, the present study is the first to investigate rat fetal lung development 
using DNA microarray and is different from the previous studies in several ways. 1) We used a 
loop design to directly compare two adjacent time points. Therefore, the number of accumulated 
errors was decreased. 2) We performed 16 hybridizations for each sample and, thus, had a 
relatively large number of biological and technical replications. As a result, the accuracy of the 
experiments was increased. Indeed, real-time PCR verified 88% of the selected genes if compare 
the gene expression changes between two adjacent time points. 3) We focused on the late stage 
of fetal lung development (D18 to NB) to identify the genes involved in cell proliferation and 
differentiation. This also enabled us to perform a detailed study during this stage with a fetal lung 
sample from each day. 4) Using cluster analysis combined with GO, we were able to identify a 
novel differentiation cluster composed of 10 known genes and 5 ESTs involved in cell proliferation, 
cell differentiation, and development.  
Some genes identified in our study have expression patterns similar to those in mice, such 
as Dlk1, glyceraldehyde-3-phosphate dehydrogenase, and a number of genes in the tyrosine 
kinase family. However, a significant number of the genes identified in our study are different from 
those identified in the mouse studies (2, 38), perhaps because of species difference. Comparative 
studies revealed different gene profiles of the lungs in response to hypoxia between the rat and 
the mouse (19). Another possible reason is the difference in DNA microarray platforms and data 
analysis.  
During fetal lung development, cell proliferation and cell population undergo dynamic 
changes. The rate of cell proliferation increases at the pseudoglandular stage and declines at the 
canalicular and saccular stages. However, the percentage of dividing interstitial cells decreases 
from gestational day 17 to day 20 and then markedly increases on day 20. An opposite trend is 
seen for epithelial cells (1). This raises the possibility that some of the changes in gene 
expression may reflect the difference in cell population in the developing lung. Although we 
cannot rule out the possibility, the changes in gene expression in cluster 5 seem not to 
correspond to cell population, at least in the fetal stages (1). The change in Ptn mRNA between 
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prenatal and adult stages is tremendous (>100-fold) and is probably not due to fewer 
mesenchymal cells in the adult lung.  
Two genes, Ptn and Lhx3, were further characterized at mRNA and protein levels. Ptn and 
Lhx3 were located in fetal lung fibroblasts and epithelial cells, respectively. Ptn, an 18-kDa 
heparin-binding cytokine (13), is highly expressed in the late stage of embryogenesis (17, 33, 77) 
and postnatally in the nervous system (66). It shares 50% sequence homology with midkine, 
which may play a role in lung morphogenesis. In contrast to Ptn, midkine is primarily localized in 
epithelial cells of mouse lung from gestational day 18 to birth. Its expression is high from 
gestational days 13–16 but low from day 18 to birth and is undetectable in adult lungs (55). 
Midkine expression is stimulated by retinoic acid but inhibited by glucocorticoid (26).  
Ptn acts through two cell surface receptors, anaplastic lymphoma kinase (ALK) and the 
protein tyrosine phosphatase receptor RPTP/. ALK is the receptor tyrosine kinase that is 
expressed in the developing nervous systems and some tumor cells (25, 44). On binding with Ptn, 
ALK activates the Ras-MAPK and the phosphatidylinositol 3-kinase-Akt signaling pathways (54, 
70), leading to the stimulation of cell proliferation and the inhibition of apoptosis.  
Ptn also regulates -catenin phosphorylation through RPTP/. In the absence of Ptn, -
catenin is associated with E-cadherin. The binding of Ptn to RPTP/ results in the dimerization 
and inactivation of the receptor and, thus, an increase of the tyrosine phosphorylation of -catenin 
(42). Phosphorylated -catenin rapidly dissociates from E-cadherin. Recently, Fyn, a member of 
the Src family (51), and -adducin (52) have been found to be downstream targets of the 
Ptn/RPTP/ signaling pathway. Because it is the central component of the Wnt signaling 
pathway (82), -catenin may be a link between Ptn and Wnt signaling pathways. However, the 
association between these two pathways and the possible role of the Ptn/ RPTP/ pathway in 
fetal lung development remain to be determined.  
Lhx3, one of the LIM homeodomain transcription factors, is essential for pituitary 
development and function (11). Mutations in the human Lhx3 gene result in severe endocrine 
disease and cause a deficiency in all anterior pituitary hormones except adrenocorticotropin (47, 
68). Lhx3 is thought to be one of the genes that play an important role in the development of 
Rathke's pouch, beginning at around embryonic day 8.5 in the mouse (64). In situ hybridization 
reveals the highest expression of Lhx3 in the developing lung and pituitary (61). However, its 
function in lung development has not been studied.  
Ephrin (Eph) A3 is a GPI-anchored membrane glycoprotein and a ligand for Eph receptors. 
The binding of clustered Eph to Eph receptors activates the downstream cascade of the Eph 
signaling pathway and regulates vascular aggregation and homeostasis. Recently, EphA3 has 
been identified as a downstream protein of the Wnt-Frizzled signaling pathway (32). Wnt 
modulates lung morphogenesis through the canonical -catenin/lymphocyte enhanger factor-T 
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cell factor pathway (45). In the presence of Wnt, -catenin is stabilized and accumulates in the 
nucleus to activate transcription of its downstream genes, such as N-myc, bone morphogenetic 
protein 4 (Bmp4), and fibroblast growth factor (FGF) (65).  
Dlk1 belongs to the family of epithelial growth factor-like homeotic proteins that are involved 
in regulating growth and differentiation through cell-cell interaction. Dlk1 inhibits the differentiation 
of preadipocytes to mature adipocytes (67). Dlk1 acts through the Notch pathway (24). The 
binding of their ligands, Delta-like or Jagged, with Notch receptors results in a proteolytic cleavage 
of the Notch intracellular domain. The latter translocates into the nucleus and associates with a 
transcription factor, RBP-Jk. As a result, it activates expression of the downstream target genes, 
including hairy and enhancer of split (Hes) and Hes-related repressor protein transcriptional 
repressors. In situ hybridization of fetal lung mouse tissue shows that Dlk1 expression is high on 
gestational day 12.5 but downregulated on day 16.5 (85), similar to our microarray results.  
Adh3 catalyzes the synthesis of retinoic acid, a biologically active derivative of vitamin A. 
Retinoic acid is important for lung branching morphogenesis (36). It regulates expression of the 
genes encoding for surfactant proteins and the enzymes that produce surfactant lipids (78). Adh3 
expression is turned on at the late stages of liver development (76), but its temporal expression 
during fetal lung development is unknown.  
Cadherin-22 is responsible for Ca2+-dependent cell-cell adhesion and is one of the important 
membrane proteins for mesenchymal-epithelial interaction in brain development (4, 22). 
Cadherin-22 is temporally and spatially expressed in the developing brain; its mRNA expression 
reached the highest level during the early postnatal stage and then declined at day 10 (71). 
Whether NADH/NADH thyroid oxidase-2 and glycogenin regulate fetal lung development has not 
been studied, but the similarity between their expression patterns and those of the other 
development-associated genes in this cluster suggests that they might have roles in this process.  
The power of DNA microarray data is to generate hypotheses for further functional studies. 
From our gene expression data and the gene functions in cluster 5, we proposed a working model 
for regulation of fetal lung development and alveolar epithelial type II cell differentiation. However, 
we should emphasize that these pathways in fetal lung cells are highly speculative at this stage, 
because we have not determined the expression of each component in respective cells (except 
Ptn and Lhx3) as well as their interactions. In fetal lung fibroblasts or other mesenchymal cells, 
Adh3 catalyzes the synthesis of retinoic acid, which translocates into the nucleus and stimulates 
expression of Ptn. After its secretion, Ptn binds to the RPTP/ on the surface of epithelial type II 
cells. This inhibits the phosphatase activity of RPTP/ and rapidly increases the tyrosine 
phosphorylation of -catenin, which decreases its affinity to cadherin. Next, -catenin is released, 
enters the nucleus, and increases the expression of Lhx3 and other target genes. The increased 
Lhx3 expression may exert a positive-feedback regulation on its expression. Other genes in this 
		

cluster, Dlk1 via the Notch pathway and EphA3 via the Wnt pathway, may coregulate fetal lung 
development and fetal epithelial type II cell proliferation and differentiation.  
The 583 identified genes were grouped into seven clusters. Cluster 1 is composed of 101 
genes (21 ESTs and 80 known genes). The expression level of these genes was low in the fetal 
lung at day 18 and high the adult lung. The major functional categories of this cluster are 
metabolism and signal transduction. Seven genes are associated with cell proliferation. 
Phospholipase A2 group 1b (Pla2g1b) promotes cell proliferation and migration
 via receptor-
mediated effects (29). Zinc finger protein hf-1b is a ubiquitous transcription factor. However, when 
it combines with a muscle factor (hf-1b/mef-2), hf-1b confers cardiac muscle-specific gene 
expression (46). Hes3, a member of the basic helix-loop-helix transcription factor family, regulates 
mammalian neural development (34). FGF receptor 2 (FGFR2) is the most common receptor for 
FGF-1, FGF-7, and FGF-10. FGFR2–/– mice are viable until birth and show severe lung defects 
(12). Prostaglandin-endoperoxide synthase 2 (ptgs2) is a nuclear membrane protein that may 
negatively regulate cell proliferation (59). Merlin (Nf2) inhibits cell cycle progression by decreasing 
cyclin D1 expression (84). 11- Hydroxysteroid dehydrogenase type 1 (Hsd11b1) regulates lung 
maturation by synthesizing glucocorticoid locally (20). RTI40 (also called T1), a lung type I cell-
specific protein, can be used as a biochemical marker for acute lung injury (40). The 
developmental expression of hsd11b and RTI40 in the lung is consistent with our microarray data 
(21, 81).  
The 34 genes (9 ESTs and 25 known genes) in cluster 2 were decreased in the canalicular 
stage and then gradually increased in the saccular stage and declined after birth. Eight genes in 
this cluster are related to ion transport and five to development. Interestingly, four of the five 
development-related genes are involved in muscle development, including skeletal troponin I 
(Tnni2), cardiac troponin I (Tnni3), -enteric muscle actin (actg2), and cysteine-rich protein 3 
(csrp3). Tnni2 and Tnni3 are different isoforms in the thin filament-linked Ca2+ regulatory system 
in vertebrate striated muscle (49). Actg2 is a major component of the organized contractile 
apparatus of smooth muscle cells (60). Csrp3 is a LIM domain protein that promotes myogenic 
differentiation and is a novel regulator of myogenesis (5, 48). -Crystallin B (Cryab), a small heat 
shock protein involved in sensory organ development, has cytoprotective and oncogenic functions 
(50).  
Cluster 3 is the largest cluster, consisting of 152 genes (112 known genes and 40 ESTs) that 
exhibit downregulation of expression levels after birth. More than half of these genes are involved 
in metabolism; most of the metabolic proteins are ribosome proteins for protein biosynthesis. 
Additionally, five genes have roles in development or cell proliferation. High-mobility group 1 
(hmg1) may contribute to the pathogenesis of acute lung injury. Antibodies against hmg1 reduce 




a component of the synaptonemal complexes involved in chromosome pairing during meiosis (14). 
Intestine and stomach expression 1 (Mist1) is a basic helix-loop-helix transcription factor that 
regulates developmental patterns through the G protein-coupled signaling pathway (31). Myosin 
Ib (Myo1b) is a widely expressed protein involved in cell motility (51).  
Expression of the 115 genes in cluster 4 (86 known genes and 29 ESTs) was higher in adult 
than in fetal and newborn lungs. These genes may be important for normal lung function during 
adulthood. There are two major functional categories in this cluster: signal transduction and 
transport. Four genes are involved in cell growth. Latent TGF--binding protein-1- or -2-like 
proteins (Ltbp1 or Ltbp2) are extracellular matrix proteins that regulate TGF- activity (57). Activin 
A receptor type II-like-1 (Acvrl1), a member of the TGF- type I receptor family, is highly 
expressed in endothelial cells and functions in the normal development of the arterial and venous 
vascular beds (62, 75). Bmp6 regulates embryonic tissue development, cell proliferation, 
differentiation, morphogenesis, and apoptosis in multiple systems via the TGF--signaling 
pathway (18).  
The gene expression patterns in cluster 6 (40 known genes and 10 ESTs) and cluster 7 (50 
known genes and 65 ESTs) are similar. About 40% of the genes in cluster 6 and 30% of the 
genes in cluster 7 are related to metabolism. A significant percentage (10%) of the genes in 
cluster 6 are involved in development. EphB1 is a developmentally regulated membrane protein 
involved in neurogenesis (43). Its expression is induced by retinoic acid (58). In rat brain, EphB1 
mRNA level is high in the fetal stages but low in the adult (8). -Tropomyosin (56), 1-actin
 (39), 
and myogenin (83) are involved in muscle development. Protein arginine n-methyltransferase, a 
nuclear enzyme, catalyzes S-adenosyl-L-methionine-dependent methylation of arginine residues 
during organogenesis (37).  
A relatively large number of genes in cluster 7 participate in transport, signal transduction, 
and proliferation. The proliferation-related genes include TGF-, high-mobility group protein 2 
(hmg2), Ran, pituitary tumor-transforming 1 (Pttg1), and topoisomerase (DNA)-2 (Top2a). 
Except for TGF-, all the genes are nuclear proteins and involved in regulation of the cell cycle, 
protein transcription, or cell maintenance (27, 69, 72, 73). TGF- is a growth factor that regulates 
the cell cycle. Overexpression of TGF- disrupts lung morphogenesis (30) and surfactant 
homeostasis (23). Expression of TGF- is decreased during the late stage of fetal lung 
development (28).  
Gene expression profiles of fetal lungs at the late developmental stages were examined in 
this study. The 583 identified genes were clustered according to their expression patterns. Cluster 
5 contained 10 known genes and 5 ESTs that are involved in cell proliferation, cell differentiation, 
and development. In general, expression of the genes in this cluster was high in the late stage of 
fetal lung development but low in adult lungs. Most of these genes have not been studied in the 
	

lung. These genes might be incorporated into several pathways, including retinoic acid signaling, 
Ptn--catenin signaling, and the Notch and Wnt pathways. Our findings may provide important 
clues for further understanding of molecular mechanisms in fetal lung development.  
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PLEIOTROPHIN REGULATES LUNG EPITHELIAL CELL PROLIFERATION AND 
DIFFERENTIATION DURING FETAL LUNG DEVELOPMENT VIA -CATENIN AND DLK1 
 
3.1 Abstract 
The role of pleiotrophin in fetal lung development was investigated. We found that 
pleiotrophin and its receptor, protein tyrosine phosphatase receptor /, were highly expressed in 
mesenchymal and epithelial cells of the fetal lungs, respectively. Using isolated fetal alveolar 
epithelial type II cells, we demonstrated that pleiotrophin promoted fetal type II cell proliferation 
and arrested type II cell trans-differentiation into alveolar epithelial type I cells. Pleiotrophin also 
increased wound healing of injured type II cell monolayer. Knock-down of pleiotrophin influenced 
lung branching morphogenesis in a fetal lung organ culture model. Pleiotrophin increased the 
tyrosine phosphorylation of -catenin, promoted -catenin translocation into the nucleus and 
activated TCF/LEF transcription factors. Dlk1, a membrane ligand that initiates the Notch 
signaling pathway, was identified as a down-stream target of the pleiotrophin/-catenin pathway 
by endogenous dlk1 expression, promoter assay and chromatin immunoprecipitation. These 
results provide evidence that pleiotrophin regulates fetal type II cell proliferation and 
differentiation via integration of multiple signaling pathways including pleiotrophin, -catenin and 
Notch pathways.  






Fetal lung development is a complex biological process. Rat lung originates from the 
foregut endoderm as a bifurcation at embryonic day 10 (E10) and undergoes several generations 
of dichotomous branching morphogenesis to form a respiratory tree thereafter (17). The columnar 
epithelial cells differentiate into Clara cells and epithelial cells. Although surfactant protein C (SP-
C) is detected as early as E13, fetal alveolar epithelial type II cells (fAEC II) are not fully 
differentiated until E18 when glycogen-pool-enriched AEC II precurcers become cuboidal and 
differentiate into cells containing lamellar bodies. fAEC II can further differentiate and give rise to 
the alveolar epithelial type I cells (AEC I). 
The regulation of fetal lung development includes coordinated regulation of molecular 
pathways as well as reciprocal interactions among mesenchymal cells, epithelial cells and the 
extracelluar matrix (40). Precise signals from mesenchymal cells regulate lung branching 
morphogenesis and lead to cell fate determination and the subsequent generation of cell type 
diversity in the lung epithelium. For example, mesenchymal cells secrete fibroblast growth factor 
10 (FGF10) (5; 38). FGF10 in turn binds to its receptor which is located on the surface of 
epithelial cells. The binding transduces a message to downstream signaling in order to regulate 
cell proliferation, differentiation, migration and branching morphorgenesis. Similarly, the epithelial 
cells also secrete signal molecules to interact with the mesenchyme. Sonic hedgehog (Shh) is a 
growth factor expressed in the developing epithelium. Its receptor, Patched-1 (Ptc), is located on 
mesenchymal cells. The interaction between Shh and Ptc has been shown to be required for lung 
bud formation (22). Other growth factors such as platelet derived growth factor (PDGF), 
transforming growth factor (TGF-), epidermal growth factor (EGF) and vascular endothelial 
growth factor (VEGF) also play active roles in mesenchyme-epithelium interactions (40).   
 Pleiotrophin (PTN), a heparin binding cytokine, is involved in cell transformation, growth, 
survival, migration and angiogenesis (9). PTN is localized in the extracellar matrix and 
mesenchymal cells. It shares 50% sequence homology with midkine. PTN was first identified as a 
growth factor from the bovine uterus (25) and as a neurite outgrowth promoting factor in the 
neonatal rat brain (34). PTN expression peaks in the late stage of embryogenesis (16; 44) and 
postnatally in the nervous system (20; 42). PTN is also up-regulated in injured cells and is 
important for new tissue formation during recovery from injury (49). PTN levels are much lower in 
adult tissue than that in fetal tissue; however, PTN is overexpressed in a number of cancers 
including human breast cancers (46) and melanocytic tumors (39). 
PTN signals through the cell surface receptor, protein tyrosine phosphatase receptor 
(RPTP /). In U373-MG glioblastoma cells, the binding of PTN with RPTP / results in the 
dimerization and inactivation of the receptor, leading to an increase in tyrosine phosphorylation of 




the cytoskeleton. Since -catenin is the central component of the Wnt signaling pathway, there 
may be a cross-talk between PTN and Wnt signaling pathways. PTN may also act via the 
receptor tyrosine kinase, anaplastic lymphoma kinase receptor (ALK) (43).  
 There is little information available regarding PTN in the lung. PTN is expressed in fetal 
lungs (44) and lung cancer cell lines (19). Our DNA microarray analysis of fetal lungs reveals that 
ptn is highly expressed during the late stage of fetal lung development (47). This is confirmed by 
real-time PCR and Western blot. However, whether PTN has a role in fetal lung development is 
unknown. 
 In this study, we first examined the expression pattern of PTN and its receptor, RPTP / 
during fetal lung development. Using primary fAEC II, we evaluated the role of PTN in cell 
proliferation, differentiation and wound healing. We also determined the effects of PTN on fetal 
lung branching morphogenesis by knocking down the PTN expression with adenovirus-mediated 
small interfering RNA (siRNA). Finally, we dissected the signaling pathways initiated by PTN. Our 
results show that PTN regulates fetal lung epithelial cell proliferation and differentiation via -
catenin signaling pathway.  
3.3 MATERIALS AND METHODS 
3.3.1 Chemicals and reagents 
 TRI reagents were purchased from Molecular Research Center, Inc. (Cincinnati, OH). 
Oligo dT, random hexamers and pGL3 firefly luciferase reporter vector were from Promega 
(Madison, WI). RNase-freeTM DNase was from Ambion (Austin, TX). M-MLV reverse 
transcriptase, pENTR plasmid, LipfectamineTM 2000 and LTX, Minimal essential medium (MEM) 
and BGJb medium were from Invitrogen (Carlsbad, CA). SYBR Green I detection reagents were 
from Qiagen (Valencia, CA). NE-PER Nuclear and Cytoplasmic Extraction Reagents and M-PER 
mammalian protein extraction reagents were from Pierce (Rockford, IL). Protein A or G agarose 
beads were from Santa Cruz Biotechnology (Santa Cruz, CA). Matrigel, anti-RPTP / and anti--
catenin monoclonal antibodies were from BD Bioscience (Franklin Lakes, NJ). Advantage 2 
Polymerase Mix and Advantage GC Genomic Polymerase Mix were from Clontech (Mountain 
View, CA). EZ ChIP kit and anti-phosphotyrosine antibodies were from Upstate Biotechnology 
(Lake Placid, NY). Human recombinant pleiotrophin, collagenase, trypsin and DNase I were from 
Sigma-Aldrich (St. Louis, MO). Goat anti-pleiotrophin, rabbit anti-Dlk1 and mouse anti-BrdU 
antibodies were from Abcam (Cambridge, MA). Mouse anti-LB180 antibody was from Covance 
(Berkeley, CA). Alexa 568-conjugated anti-goat and Alexa 488-conjugated anti-mouse antibodies 
were from Molecular Probes (Eugene, OR). ABC reagents were from Vector Laboratories 
(Burlingame, CA). TSATM-plus HRP system was from PerkinElmer (Waltham, MA). L2 cell line 





3.3.2 Real-time PCR 
  Total RNAs were isolated using TRI reagents and treated with RNase-freeTM DNase to 
remove DNA contamination. 1 µg of total RNAs were reverse-transcribed into cDNA using oligo 
dT and random hexamers and M-MLV reverse transcriptase. The primers were designed using 
Primer Express® software (Applied Biosystems, Foster City, CA): PTN, 5’ 
ATACCAGCAGCAACGTCGAAA (forward) and 5’ GCACACACTCCATTGCCATT (reward), Dlk1, 
5’ GTGAAGAACCATGGCAGTGTGT (forward) and 5’ GACAGTCCTTTCCAGAGAATCCA 
(reward), and 18S rRNA 5’ TCCCAGTAAGTGCGGGTCATA (forward) and 5’ 
CGAGGGCCTCACTAAACCATC (reward). Real-time PCR was performed on an ABI 7500 
system using SYBR Green I detection as previously described (47). To eliminate the effects of 
primer dimers, we included a data acquisition step at a temperature of 2 ~ 5 °C lower than the 
annealing temperature of the products. After the amplification, a dissociation curve was 
generated to check the specificity of the amplification. The data were normalized to 18S rRNA.  
3.3.3 Immunohistochemistry 
Fetal lung tissues were fixed in 4% formaldehyde for 24 hrs, embedded in paraffin and 
sectioned at a 4 µm thickness. The slides were dewaxed, rehydrated, boiled in citric buffer (pH 
6.0) for 20 min for antigen retrieval and permeabilized by a 10-min incubation in 0.3% Triton X-
100. The slides were blocked in 10% normal horse serum and then incubated with goat anti-PTN 
(1:100) or mouse anti-RPTP / (1:200) at 4ºC overnight. After being rinsed with phosphate-
buffered saline (PBS, pH 7.4), the slides were further incubated in corresponding secondary 
antibodies (1:100) for 1 hr. The slides were rinsed again and incubated in ABC reagents for 30 
min. The signal was amplified using the TSATM-plus HRP system. Signal was detected using 
DAB substrate. The slides were counter-stained by hemeotoxylin and viewed under a Nikon 
Eclipse E600 microscope with a Plan Flour, ELWD 40 x/0.6 or 20x/0.5 objective lenses. The 
images were captured with an Insight 2 color mosaic camera and the basic spot software 
(Diagnostic Instruments Inc.). 
3.3.4 Immunocytochemistry 
fAEC II were fixed in 4% formaldehyde for 15 min, followed by a 10-min incubation in 
0.3% Triton X-100 for permeabilization. After being blocked in 10% fetal bovine serum (FBS) for 
30 min, the cells were incubated with anti-LB180 (1:200) or anti-T1- (1:250) antibodies at 4°C 
overnight. The cells were rinsed with PBS, and then incubated with Alexa 488-conjugated anti-
mouse antibodies (1:250) for 1 hr. Finally, cells were washed and viewed by a Nikon Eclipse 
TE2000-U inverted fluorescence microscope with a Plan Flour, ELWD 40 x/0.6 or 20 x /0.5 
objective lens. The images were captured with a Photometrics CoolSnap CCD camera (Roper 





3.3.5 fAEC II isolation and culture 
fAEC II were isolated as described (4). The Oklahoma State University Animal use and 
Care Committee approved all the procedures used in this study. Timed-Pregnant Sprague 
Dawley rats with a gestational day of 20 were sacrificed by carbon dioxide asphyxia. Fetuses 
were carefully separated from the uterus. Fetal lungs were excised from the fetuses and washed 
with cold Hanks’ balanced salt solution (HBSS). After removing the surrounding trachea, thymus 
and heart, the lungs were chopped into 1 mm3 cubes and digested with MEM containing 1 mg/ml 
collagenase, 1 mg/ml trypsin and 0.4 mg/ml DNase I for 10 min for 4 times. Released cells were 
filtered through 160 and 37 µm nylon gauze filters. The cells were then collected by centrifugation 
at 160 x g for 10 min and resuspended in MEM containing 20% FBS, 100 U/ml penicillin and 10 
µg/ml streptomycin at a final concentration of 1.7 X106 cells/ml. To remove the fibroblasts, 40 ml 
of the cells were seeded in a 20 cm plastic dish for differential adhesion. After 4 rounds of a 45-
min adherence, the cells were filtered through a 15 µm nylon gauze filter, centrifuged and seeded 
on the plate for further culture. The resulting fAEC II had a purity of ~90% and a viability of > 
95%.  
 For the trans-differentiation experiment, primary fAEC II were cultured in full MEM 
medium (FMEM, MEM supplemented with 10% FBS, 1% nonessential amino acids, and 1% 
penicillin and streptomycin) for 24 hrs. Media were changed to chemical defined serum-free 
medium (12). (DSFM, DMEM/F12 1:1 supplemented with 1.25 mg/ml bovine serum albumin, 1% 
nonessential amino acids and 1% penicillin and streptomycin) without or with 50 ng/ml human 
recombinant PTN. The cells were cultured for 4 more days and media were changed every two 
days. Finally, the cells were fixed and used for immunofluorescence.  
3.3.6 Wound healing assay 
Primary fAEC II were cultured overnight in plastic dishes in FMEM. Culture media were 
changed to DSFM in the presence of different doses of PTN. Culture continued until a monolayer 
was formed (normally on day 2). The cell monolayer were then scratched with a yellow tip to 
mimic injury and the gaps were photographed every 6 hrs. The wound width was measured, and 
the wound closure was defined as the wound width at a specific time minus the distance of the 
original wound width.  
For the co-culture experiment, primary fibroblasts were collected during the differential 
adhesion stage when isolating fAEC II. 0.5 x 106 of fAEC II were seeded outside of a collagen-
coated insert with 0.2 µm pore size and fibroblasts (0.5 x 106) were seeded inside the insert. Both 




the media were changed to DSFM and the fAEC II monolayer was scratched for the wound 
healing assay.  
3.3.7 Cell proliferation assay 
 Primary fAEC II were cultured in FMEM for 24 hrs. Then the media were changed to 
DSFM without or with 50 ng/ml PTN. The cells were cultured for additional 36 hrs. Bromodeoxy-
uridine (BrdU, 10 	M) was added to the medium 12 hrs before collecting the cells. Finally, the 
cells were fixed in 4% paraformadehyde and stained with anti-BrdU antibodies (1:100).  
3.3.8 Western blot  
Cells were lysed in the M-PER mammalian protein extraction reagent with protease 
inhibitor cocktail on ice for 10 min. The lysate was centrifuged at 12,000 xg for 10 min to clear the 
cell debris. Protein concentrations in the supernatant were determined the using the DC Protein 
Assay Kit. The same amount of total protein was separated by 10% SDS-PAGE and then 
transferred onto a nitrocellulose membrane. The membrane was blocked with 5% dry milk in Tris-
Buffered Saline (TBS) for 1 hr. Then, the membrane was incubated with primary antibodies (anti-
RPTP /: 1:500, anti--catenin: 1:1000, anti--tubulin: 1:1000, and anti-phosphotyrosine: 1:1000) 
overnight at 4°C. After being washed with TBS containing 0.05% Tween 20, the membrane was 
incubated with corresponding secondary antibodies (1:2000) for 1 hr. Finally, the membrane was 
developed with ECL reagents and exposed to X-ray film.  
 
3.3.9 Construction of siRNA adenoviral vector  
A highly efficient siRNA vector expressing 4 shRNAs under the control of mU6, hU6, H1 
and 7SK promoters was previously developed in our laboratory (14). Four siRNA sequences 
specific to the coding region of PTN (549-569, 570-590, 607-627 and 909-929) were selected 
based on the computer program (http://i.cs.hku.hk/~sirna/software/sirna.php). A vector containing 
4 unrelated siRNA sequences was used as a control. These siRNA sequences were cloned into a 
modified pENTR plasmid containing a CMV-driven EGFP protein for tracking the virus 
transduction. The siRNA and EGFP sequences were transferred from the pENTR recombinant 
vector to the adenoviral vector, pAd/PL-DEST vector by a LR recombinant reaction using the 
Gateway technology. The plasmid from the positive clone was digested with Pac I and 
transfected into a 293A producer cell line with the LipfectamineTM 2000 reagent. The adenovirus-
containing cells were harvested, and the generated virus was used to infect 293A cells to amplify 
the viral stock. The titer was determined by counting the GFP positive cells. 




Timed-pregnant rats with a gestational day 14 (E14) were killed by CO2 asphyxia. 
Embryos were carefully removed from the uterus and placed in cold HBSS. Fetal lungs were 
isolated from the fetus by microdissection needles. Two or three lungs were kept on a 3 cm 
insert, which were placed in a 6-well plate with 1.5 ml BGJb supplemented with 100 U/ml 
penicillin, 100 µg/ml streptomycin, and 0.2 mg/ml ascorbic acid. The fetal lungs were cultured for 
1 to 3 days. The viruses were added to the lungs inside of the insert at day 0, moved outside of 
the insert after a 3-hr treatment and removed after 24 hrs. Medium was changed every day. The 
fetal lungs were photographed every 24 hrs to record the morphological changes. To determine 
the changes in lung branching morphogenesis, the terminal buds of each lung were counted and 
normalized to those at day 0 of the same lung. The sizes of terminal and inside buds were 
determined with Metaview™ (Universal Imaging Corporation). About 30 buds were evaluated for 
each lung.    
3.3.11 Tyrosine phosphorylation of -catenin 
Primary fAEC II were cultured in FMEM for one day, and then in DSFM for an additional 
day. The cells were treated with 50 ng/ml PTN for 0, 5, 10, 20, 60 or 120 min and lyzed in the M-
PER mammalian protein extraction reagent (supplemented with 1% Halt phosphatase inhibitor 
cocktail and 1% protease inhibitor cocktail, and 1 mM sodium orthovanadate). The cell lysate 
(250 	g protein) were incubated with anti--catenin antibodies (2 	g) at 4°C for 2 hrs. 10 µl 
protein A and 20 µl protein G agarose beads were added to the mixtures and incubated overnight 
at 4°C by gentle end-to-end mixing. The agarose beads were washed 6 times with PBS. The 
proteins were eluted by boiling in 1X SDS sample buffer for detection of phosphorylation and -
catenin by Western blotting.  
3.3.12 Translocation of -catenin 
 Primary fAEC II were cultured in FMEM for 24 hrs and in DSFM for another 24 hrs. The 
cells were treated with 50 or 100 ng/ml PTN for 12 hrs. The nuclear and cytoplasmic fractions 
were separated using the NE-PER Nuclear and Cytoplasmic Extraction Reagents. The amounts 
of -catenin in the cytoplasmic and nuclear fractions were determined using Western blot.  
3.3.13 fAEC II culture on Matrigel 
 Matrigel was thawed fully at 4°C overnight, and kept on ice until use. 200 	l of Matrigel 
was added to each well of 12-well plate and incubated for 1 hr at room temperature to 
solidification. Primary fAEC II was seeded at a density of 5 x 105 cells/well in FMEM. After 24 hrs, 
media were changed to DSFM and the cells were treated with various concentrations of Wnt3a or 
LiCl for 48 hrs. The cells were collected in 1 ml Tri-reagent for isolation of total RNA. 




 Freshly isolated fAEC II (5 x 106) were transfected with phRL-TK (1.14 µg) and TOPflash 
or FOPflash (1.3 µg) by electroporation using the Amaxa NHBE Nucleofector kit for normal 
human bronchial epithelial cells and the Program T-13. The cells (2.5 x 106/well) were seeded in 
a 48-well plate and cultured in 10% FBS-DMEM for 24 hrs. The fAEC II were then treated with 
100 ng/ml PTN for 24 hrs and harvested for a dual-luciferase assay.  
3.3.15 Dlk 1 promoter assay  
The Dlk1 promoter (-1471 to 190) was amplified from mouse genomic DNA by overlap 
PCR. Three sets of primers were designed to amply Dlk1 promoter from mouse genomic DNA. 
The first fragment A (631 bp) ranging from -1471 to -848 was amplified by Advantage 2 
Polymerase Mix with the primers (5’-CGTGCTAGCCAAAGGAGCTATGTCAATGAC-3’ and 5’- 
AGCACTGATTCTTTCCAACATG-3’). The second fragment B (624 bp) ranging from -894 to -271 
and the third fragment C (503 bp) ranging from -305 to 190 were amplified by Advantage GC 




GCCAAGCTTGGAGGGCTCCGGTCGCGATCATCTC-3’). Using the gel-purified three Dlk1 
fragments mixture as template, the full-length Dlk1 promoter was obtained by over-lap PCR with 
two outside primers (5’-CGTGCTAGCCAAAGGAGCTATGTCAATGAC-3’ and 5’- 
GCCAAGCTTGGAGGGCTCCGGTCGCGATCATCTC-3’). The purified PCR products were 
digested by Nhe1 and Hind3 and cloned into the pGL3 firefly luciferase reporter vector to replace 
the SV40 promoter through Nhe1-Hind3 sites. The amplified Dlk1 promoter was verified by DNA 
sequencing. The Dlk1 promoter-driven firefly luciferase vector was named as pDlk1-Fluc. 
Freshly isolated fAEC II (4 x 106) were transfected with 1 µg pDlk1-Fluc, 1.14 µg Renilla 
luciferase vector phRL-TK, 100 or 500 ng wild type -catenin or constructively activated mutant 
∆GSK -catenin using the Amexa Nucleofector kit for normal human bronchial epithelial cells and 
the Program T-13. The cells (2 x 106/well) were seeded into a 48-well plate and cultured in 10% 
FBS-DMEM for 24 hrs. The medium was changed with fresh 10% FBS-DMEM medium with or 
without PTN (100 ng/ml) and the cells were harvested for dual luciferase assay after a 24-hr 
treatment. 
3.3.16 Chromatin Immunoprecipitation (ChIP) 
The EZ ChIP kit was used for the CHIP assay. fAEC II were fixed in 1% formaldehyde in 
PBS for 10 min at room temperature. Then, glycine was added at a final concentration of 0.125 M 
to stop the cross-linking. 6 x 106 cells were washed by cold PBS for 2 times and then sonicated in 
300 µl SDS lysis buffer (Branson Sonifier 450, Output power 7, 20 seconds for 20 times). For 
each sample, chromatin from 1.5 x 106 cells was immunoprecipitated with 2 µg normal mouse 

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IgG, or mouse monoclonal antibody for -catenin as described in the kit manual. After reversal of 
the cross-linking by adding 200 mM NaCl and incubating at 65°C overnight, 2 µl of purified 
immuno-selected DNAs were used for PCR (32 cycles, 94 °C, 30 s; 56°C, 30 s; 72°C, 30 s). 5 µl 
of the reaction products were run on 1.5% agarose gel. Two pairs of primers were used to amplify 
two putative TCF/LEF binding sites and flanking sequences: Dlk1-BS1, forward, 
5’TGGAGATTAAATTCAAGCTGTCAG3’ and reverse, 5’GCAGCCAAACTTGAGTTTGATC3’; 
Dlk1-BS2, forward, 5’CATTTGAC<R>GTGAACATATTGG3’ (R=A/G) and reverse, 5’ 
GCCCAG<W>CCCCAAATCTGTC3’ (W=A/T). The degenerated primers were designed to 
amplify both rat and mouse Dlk1 promoter sequences. CCDN1 promoter fragment (-173-+117) 
was amplified as a positive control for TCF/LEF binding using a primer pair: forward, 
5’TTCTCTGCCCGGCTTTGAT3’ and reverse, 5’CACAGGAGCTGGTGTTCCATG3’. GAPDH 
promoter, which has no TCF/LEF binding site, served as a negative control and was amplified 




3.4.1 PTN and its receptor, RPTP / expression in the developing lung 
    We have previously shown that PTN mRNA and protein are highly expressed in the late stage 
of fetal lung development by analyzing fetal lungs at different gestational days as well as lungs of 
newborn and adult rats using DNA microarray analysis, real-time PCR and Western blot (47). We 
further investigated temporal and spatial expression of PTN during rat lung development by ABC 
immunostaining. PTN was barely detectable in the embryonic day (E16) lungs (Fig.III.1A). A 
strong staining in the mesenchyme adjacent to the developing epithelium and endothelium of the 
E18 and E20 lungs was seen. Little PTN signals were observed in adult lungs. No positive signals 
were found in the negative controls without primary antibodies (data not shown). Real-time PCR 





Fig.III.1. PTN expression during fetal lung development. (A) Immunostaining of PTN in the 
developing lungs. Embryonic day 16, 18, and 20 (E16, E18, E20) and adult (AD) lung tissue 
sections were stained using anti-PTN antibodies and the Vectastain ABC kit. Scale: 100 µm. The 
lower right two panels are high magnifications (Scale bar: 20 µm). (B) Real-time PCR analysis of 
PTN mRNA expression in E19 fetal lung tissue (E19) and isolated E19 fetal fibroblasts (FFIB). 
The results were normalized to 18S rRNA and expressed as a ratio of lung tissue. Data shown 











Fig.III.2. RPTP / expression during fetal lung development. (A) mRNA levels of RPTP / in 
lung tissues; (B) Protein levels of RPTP / in lung tissues; (C) mRNA levels of RPTP / in 
various cells. mRNA and protein levels were determined by real-time PCR and Western blot. 
E18-E21: fetal lungs; PD1 and PD14: postnatal day 1 and 14 lungs. AD: adult lungs. AdAECII: 
adult type II cells; fAEC II: E20 primary fetal type II cells; L2: a cell line derived from adult rat 
lungs. The mRNA levels were normalized to 18S rRNA and expressed as a percentage of AD or 
AdAECII. Data shown are means ± S.E. (n=6) (D) Immunostaining of E16, 18, 20 and AD lungs 
with anti-RPTP / antibodies. Scale Bar: 50 µm 
 
We also examined the expression of RPTP /, one of the PTN receptors, during fetal 
lung development. As shown by real-time PCR, RPTP / mRNA was highly expressed in E18 
and E19 fetal lungs (Fig.III.2A). Western blot revealed 3 bands with molecular masses of 230, 
130 and 85 kDa (Fig.III.2B), which correspond to 3 alternatively spliced species of RPTP / (24). 
The RPTP / protein was highly expressed in E18-21 fetal lungs, but relatively low in postnatal 
day 1, day 14 and adult lung tissues. A high expression of RPTP / protein in the E21 lungs in 
comparison with mRNA may be due to its stability. The time-restricted RPTP / expression 
corresponds with the PTN expression, indicating that the PTN pathway may be active during the 
late stage of fetal lung development. To further identify which types of cells express RPTP /, 
real-time PCR was used to examine the RPTP / mRNA expression level in fAEC II, adult type II 
cells (ADAEC II) and L2 cells (a rat lung epithelial cell line derived from the adult rat lung). RPTP 
/ expressed highly in fAEC II but lowly in ADAEC II (Fig.III.2C). L2 had no expression of the 
receptor. RPTP / cellular localization was further viewed using ABC staining in E16, E18, E20 
and adult lung tissues. As shown in Fig.III.2D, RPTP / staining was strong in E18 and E20 
lungs but was not detectable in E16 or adult lungs. Consistent with the real-time PCR results, 
RPTP / was localized in airway epithelial cells. 
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3.4.2 PTN arrests fAEC II trans-differentiation into AEC I  
 
Fig.III.3. Effect of PTN on fAEC II trans-differentiation. Primary fAEC II were cultured for 1 or 5 
days on plastics. PTN (50 ng/ml) was added at day 1. ABCA3 (type II cell marker) and T1 (Type 
I cell marker) were stained by immunofluorescence. 
 
When AEC II were cultured on plastic dishes, the cells gradually lost the AEC II 
phenotype and trans-differentiated into AEC I. Using this in vitro system, we examined the effect 
of PTN on fAEC II trans-differentiation. Primary fAEC II were cultured on plastic dishes overnight 
and then treated with 50 ng/ml of PTN. After being cultured for 4 more days, AEC II cells were 
stained with antibodies against ABCA3 (AEC II specific marker) and T1 (AEC I specific marker). 
At day 1, the cells had strong ABCA3 staining, but weak T1 staining (Fig.III.3). After day 5 of 
culture, the control cells had no ABCA3 staining and a clear T1 staining, indicating that fAEC II 
trans-differentiated into AEC I. However, in the PTN-treated fAEC II, strong ABCA3 staining still 
remained. The results suggest that PTN can arrest the fAEC II trans-differentiation into AEC I. 
3.4.3 PTN increases fAEC II proliferation 
 To determine whether PTN can promote fAEC II proliferation, primary fAEC II were 










antibodies to view the proliferating cells. As shown in Fig.III.4, the PTN-treated cells contained 
about twice as much proliferating cells as the control cells without any treatment. 
 
Fig.III.4. PTN stimulates fAEC II proliferation. Primary fAEC II were cultured in serum-free 
medium on plastic dishes. The cells were treated with 50 ng/ml PTN at day 1. After 36 hours, the 
cells were collected and stained with anti-BrdU antibodies to view the proliferating cells. (A) 
Representative images. BF: brightfield. (B) Quantitation. The proliferating cells (BrdU-positive 
cells) were expressed as a percentage of total cells (means ± S.E.). *P<0.05 v.s. Control, n=5. 
 
3.4.4 PTN promotes wound healing 
We determined whether PTN enhances alveolar epithelial cell repair. fAEC II were cultured in 
serum-free medium with PTN. After washing, a linear wound was created using a pipette tip and 
the bright field images were taken at various time points. PTN significantly increased the wound 
closure of fAEC II in a dose-dependent manner (Fig.III.5A). The wound closure was further 
quantified as the gap width at 0 h minus the gap width at late time points (Fig.III.5B). When anti-
PTN antibody was added together with PTN, the wound closure induced by PTN was blocked 
(Fig.III.5C). The control IgG had no effects. Since PTN was enriched in fetal lung fibroblasts, we 
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further examined whether it was the PTN secreted from the fibroblasts that are responsible for 
fAEC II repair. fAEC II were co-cultured in a 6-well plate with fetal lung fibroblasts in a transwell 
insert placed in the plate and thus fibroblasts may secrete growth factors into the AEC II culture 
medium. Fibroblasts significantly promoted the fAEC II wound closure. This effect was again 
blocked by PTN antibodies, but not the control IgG. These results indicate that PTN is secreted 
from fibroblasts and acts on fAEC II to promote wound healing. 
Previously, PTN was reported to be able to stimulate the epithelial-mesenchymal-like 
transition by altering actin cytoskeleton organization (29). We examined whether PTN influences 
F-actin distribution. fAEC II treated with PTN were stained with Alexa Fluor 568 tagged phalloidin. 
The cells that were away from the scratched gap did not show much difference in stimulated and 
nonstimulated cells (data not shown). However, the PTN-treated cells on the edge of the wound 
gap had sharper and longer F-actin staining compared to untreated control cells (Fig.III.5E). The 
re-distribution of the actin cytoskeleton would allow the cells to migrate. 
 
Fig.III.5. PTN promotes wound healing of fAEC II monolayer. (A) fAEC II were isolated from E20 
lungs and cultured for 2 days. Different doses of PTN were added at day 1. On day 2, fAEC II 
monolayers were scratched and the generated gaps were photographed every 5 hrs. (B) Wound 































width. (C) Effect of anti-PTN antibodies. PTN (100 ng/ml) was added at day 1 with or without anti-
PTN antibodies or IgG (2 µg/ml). Wound closure was measured 16 hrs after the scratching and 
expressed as a percentage of control. (D) fAEC II were co-cultured with fibroblasts on transwell 
inserts. Anti-PTN antibodies or IgG (2 µg/ml) were added at day 1. fAEC II cultured in the insert 
alone in the absence (control) or presence of PTN (100 ng/ml) were used as negative and 
positive controls. Wound closure was measured 16 hrs after the scratching. Fib: fibroblasts; Fib-
a-PTN (fibroblasts plus anti-PTN antibodies; Fib-IgG: fibroblasts plus IgG. All data shown are 
means ± S.E. *P<0.05 v.s. control; **P<0.05 v.s. PTN; # P<0.05 v.s. fibroblasts, n=3 independent 
cell preparations. (E) F-actin Staining. The control and PTN-treated fAEC II at the end of wound 
healing assay were fixed in 4% Formaldehyde for 30 min, permeabilized in 1% Triton X-100 for 
10 min, and blocked in 10% FBS and 1% BSA for 15 min. The cells were then incubated with 1 
µM Alexa Fluor 568 Phalloidin for 1.5 hrs at 4 °C. After wash, the fluorescence images were 
viewed under a Nikon Inverted Fluorescence Microscope. 
3.4.5 PTN promotes fetal lung branching morphogenesis 
 Since PTN has been shown to play an important role in renal branching morphogenesis 
(37), we sought to determine if PTN plays a role in fetal lung branching morphogenesis. We 
silenced PTN in a fetal lung organ culture by using the pK4-shRNA vector (14) and examined the 
effects of the treatment on lung branching morphogenesis. An adenoviral vector carrying 4 
siRNAs targeted to the different regions of rat PTN was constructed to knockdown PTN and 
another vector with 4 non-relevant siRNAs as a control. The vectors contain CMV promoter-
driven GFP for monitoring transduction efficiency. The silencing efficiency of the PTN adenovirus 
was over 90% as tested in fetal lung fibroblasts (data not shown). E14 fetal lungs were cultured 3 
days on 30 mm Millicell inserts (Millipore) placed in six-well plates with 1.5 ml of BGJb medium in 
each well in the presence of various doses of viruses. The transduction efficiency gradually 
increased as a function of virus dose as seen by GFP fluorescence (Fig.III.6A). Western blot 
analysis also revealed an increase in GFP expression with increasing amounts of viruses 
(Fig.III.6B). The quantitation of transduction efficiency as GFP expression level was shown in 
Fig.III.6C. The silencing efficiency increased as measured by PTN mRNA levels when dose 
increased and reached a maximum level at 30 x 107 pfu (Fig.III.6C and 6D). The PTN protein 
level was also decreased by the PTN siRNA (Fig.III.6E). The control virus had no effect on PTN 
mRNA and protein levels expression (Fig.III.6D and 6E). Cell viability was not significantly 
changed as determined by measuring LDH release (Fig.III.6C). In lungs infected with siRNA 
adenovirus, the counts of terminal buds decreased (Fig.III.6F and 6G). The control virus had no 
significant effects on terminal bud numbers. There were no significant differences on the sizes of 
terminal buds on surface and inside of the lungs between siRNA-treated and control virus-treated 























































































































Fig.III.6. Effect of PTN on fetal lung branching morphogenesis. (A-C) E14 fetal lungs were 
isolated and treated with various doses of a PTN siRNA adenovirus or a virus control. GFP 
fluorescence was taken at day 3 (A) and fetal lung tissues were analyzed by Western blot using 
anti-GFP antibodies (B). The transduction efficiency, silencing efficiency and cell viability were 
monitored and expressed as a percentage of untreated lungs or a maximal value (C). 
Transduction efficiency was measured by determining GFP expression levels. Silencing efficiency 
was measured by determining ptn mRNA levels using real-time PCR. mRNA levels were 
normalized to 18S rRNA. Viability was measured by determining LDH release. (D-H) E14 fetal 
lungs were treated with a PTN siRNA adenovirus or a virus control (34 x 107 pfu) for 3 days. PTN 
mRNA (D) and protein (E) levels were determined by real-time PCR and Western blot. 
Photographs were taken at day 0 to day 3 (D0-D3) (F). Terminal bud numbers (G) were counted 
and normalized to D0. The sizes of terminal buds on surface and inside of the lungs were also 
measured at D3 (H). Data shown are means ± S.E. n=6 from 3 different pregnant rats. 
 
3.4.6 PTN signals through the RPTP / and -catenin pathway 
 We hypothesized that the binding of PTN to the RPTP / receptor would lead to its 
inactivation and an increase in -catenin tyrosine phosphorylation, causing the translocation of -
catenin into nuclei. To examine whether PTN stimulates tyrosine phosphorylation of -catenin, 
fAEC II were serum-starved for 24 hrs and incubated with PTN (50 ng/ml) for 0-120 min. At the 
end of incubation, the cells were lysed and immunoprecipitated with anti--catenin antibodies, 
followed by Western blot using anti-phosphotyrosine antibodies. As shown in Fig.III.7A, PTN 
increased tyrosine phosphorylation of -catenin in a time-dependent manner with a peak at 10-60 
min. The tyrosine phosphorylation of -catenin decreased after a 2-hr treatment. 
 We next examined whether PTN can cause -catenin translocation into the nuclei. fAEC 
II were treated with PTN for 6 hrs. The cells were then collected and the nuclei were isolated. As 




Fig.III.7. PTN initiates signaling pathway through RPTP / and -catenin. (A) Tyrosine 
phosphorylation. fAEC II were serum-starved overnight and stimulated with 50 ng/ml PTN for 0-
120 min. -catenin was immunoprecipitated (IP) with anti--catenin antibodies and probed by 
Western blot (WB) with anti-phosphotyrosine (P-Y). (B) -catenin translocation. fAECII were 
cultured on plastic dishes for 2 days and then treated with 50 or 100 ng/ml PTN for 6 hrs in 
serum-free medium. -catenin amounts in the cytoplasma and nucleus were examined using 
Western blot. GAPDH and -tubulin were used as cytoplasmic and nuclear markers as well as 
loading controls. (C) TOPflash assay for TCF/LEF activation. fAEC II were transfected with 
TOPflash or FOPflash and phRL-TK Renilla luciferase and then treated with PTN (100 ng/ml) for 
an additional 24 hrs. The Firefly and Renilla luciferase activities were determined. The results 
were expressed as a percentage of control (untreated cells). Data shown are means ± S.E. 
*P<0.05 v.s. control, n=9, 3 cell preparations assayed in triplicate. 
 
To further examine whether the cellular translocation of -catenin subsequently activates 
TCF/LEF transcription factors, we used a reporter gene TOPflash assay to determine the activity 
of TCF/LEF transcription factors. The TOPflash plasmid contains multiple copies of the TCF/LEF 
binding site and a thymidine kinase minimal promoter-driven firefly luciferase. We transfected 
primary fAEC II with the Amaxa Nucleofector due to its high transfection efficiency on primary 
cells. We achieved >60% transfection efficiency using the NHBE Nucleofector kit for normal 
human bronchial epithelial cells and the Program T-13 as tested by a CMV-GFP vector. As 
shown in Fig.III.7C, PTN increased the luciferase activity. However, PTN had little effect on 
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FOPflash, a negative control that has a mutated TCF site in the TOPflash. The results suggest 
that PTN activates TCF/LEF transcription factors. 
3.4.7 Dlk1 is a down-stream target of PTN signaling 
-catenin/TCF can be activated by LiCl or Wnt ligand. We determined whether LiCl or 
Wnt3a affects Dlk1 expression in primary fAEC II. E20 fAEC II were cultured on matrigel for 24 
hrs and treated with Wnt3a (0-20 ng/ml) or LiCl (0-20 mM) for 2 days. As shown in Fig.III.8A and 
B, both LiCl and Wnt3a decreased Dlk1 mRNA expression. The maximal inhibition was 44% and 
73% for Wnt3a and LiCl, respectively. 
We further examined whether -catenin affected Dlk1 promoter activity. We co-
transfected freshly isolated E20 fAEC II with pDlk1-FLluc, phRL-TK Renilla luciferase and wild 
type -catenin. After overnight culture, the cells were stimulated with PTN (100 ng/ml). As shown 
in Fig.III.8C, co-transfection of -catenin decreased Dlk1 promoter activity in a dose-dependent 
manner. The addition of PTN further reduced the Dlk1 promoter activity. 
GSK--catenin is a 
constitutively active form of -catenin, which has 4 point mutations in the GSK-3 
phosphorylation sites of -catenin (S/T >A) and thus cannot be phosphorylated by GSK-3 (3). 

GSK--catenin had more profound effects on Dlk1 promoter activity. The results suggest that 
PTN and -catenin regulate Dlk1 gene expression at the transcriptional level. It is worthy to note 
that PTN did not influence the Dlk1 promoter activity in the absence of co-transfection of -
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Fig.III.8. Effects of the activation of -catenin pathway on Dlk1 expression. fAEC II were cultured 
on Matrigel with various concentrations of Wnt3a (A) or LiCl (B). dlk1 mRNA level was 
determined by real-time PCR and normalized to 18S rRNA. Data shown are means ± S.E., *P< 
0.05 v.s. untreated control cells (0), n=6, assayed in duplicate from 3 independent cell 
preparations. (C) Effect of -catenin on Dlk1 promoter activity. fAEC II (3 x 106) were co-
transfected with pDlk1-FLluc, phRL-TK and wt -catenin or ∆GSK -catenin mutant by the Amaxa 
Nucleofector. After a 24-hr culture, the cells were incubated with PTN for 24 hrs. The Dlk1 
promoter activity was expressed as a ratio of Firefly over Renilla luciferase activities. Data shown 
are means ± S.E. *P<0.05 v.s. control (without wt -catenin and PTN treatment); **P<0.05 v.s 
minus PTN and 100 ng -catenin. n=3 independent cell preparations. 
 
To determine whether Dlk1 is a direct target of TCF/LEF, we performed a Chromatin 
Immunoprecipitation (ChIP) assay using the EZ ChIP kit. E20 fAEC II (1.5 x106) were treated with 
20 ng/ml Wnt3a for 8 hrs. The chromatin was immunoprecipitated with 2 µg normal mouse IgG, 
or mouse monoclonal antibodies against -catenin. The immuno-selected DNAs were amplified 
using the primers for two putative TCF/LEF binding sites (Dlk1-BS1 and Dlk1-BS2) and the 
flanking sequences of the Dlk1 promoter (Fig.III.9A). Wnt3a increased the binding of -catenin to 
the promoter of cyclin D1 (CNND1), a known target of TCF/LEF/-catenin (Fig.III.9B). -catenin 
did not bind to the promoter of GAPDH that does not contain the TCF/LEF binding site. -catenin 
bound to both TCF/LEF binding sites on the Dlk1 promoter and this binding was enhanced by 
Wnt3a (Fig.III.9B). The negative control using normal mouse IgG did not have any bands. These 




Fig.III.9. ChIP assay showing that Dlk1 is a direct target of TCF/LEF in fAEC II. (A) Two putative 
TCF/LEF binding sites (Dlk1-BS1, -1399 to -1392 and Dlk1-BS2, -974 to -967) of the Dlk1 
promoter. The arrows indicate primers used for PCR amplification. (B) The immunoprecipitated 
DNAs using anti--catenin antibodies were PCR-amplified using the primer pairs for Dlk1-BS1 
and Dlk1-BS2. GAPDH and cyclin D1 (CNND1) served as negative and positive controls, 
respectively. Normal IgG was used as an IP control. 
 
3.5 DISCUSSION 
In this study, we investigated the role of PTN in fetal epithelial cell proliferation and 
differentiation and underlying mechanisms. PTN and its receptor, RPTP / were found in 
mesenchymal and epithelial cells of the fetal lungs at the late stages of development. PTN 
promoted fAEC II proliferation and epithelial repair, but inhibited fAEC II trans-differentiation into 
AEC I. The knockdown of PTN in E14 fetal lung organ culture decreased lung branching 
morphogenesis. Furthermore, PTN increased the tyrosine phosphorylation of -catenin and 
translocation of -catenin into the nucleus, and activated the TCF/LEF transcription factors, 
leading to transcriptional depression of Dlk1.   
Fetal lung development are divided into 5 stages: embroyonic (E0-13); pseudoglandular 
(E13-18); canalicular (E18-20); sacular (E20 – term) and alveolar stages (term – adult). 

















the formation of buds from the outmost periphery of the epithelial tubes. Alveolar epithelial cell 
differentiation is a two-step process. At the canalicular stage, the columnar epithelial cells or pre-
type II cells differentiate into mature type II cells, which in turn trans-differentiate into type I cells 
in the secular stage. PTN has multiple roles in fetal lung development at various stages. PTN is 
necessary for lung branching morphogenesis at the early stage of development; PTN also 
promotes epithelial type II cell proliferation and migration but suppresses the trans-differentiation 
of type II cells into type I cells at the late stage of development.  
At 50 ng/ml, PTN has a marked effect on cell proliferation and differentiation. However, 
this dose appears to have a modest effect on wound healing and a higher dose is required for this 
assay. It is therefore likely that there are different effective doses for different functional 
consequences caused by PTN. 
PTN has been reported to be highly expressed during the late stages of embryogenesis 
(16; 20; 44). Our previous real-time PCR and Western blot results have shown that PTN mRNA 
and protein expression levels were high at the late stage of fetal lung development (47). The 
current detailed immunohistochemical studies of fetal lungs at different stages confirmed that 
PTN was mainly expressed in mesenchymal cells surrounding the epithelium at E18 to E20. 
Similar analyses of the PTN receptor, RPTP / revealed its localization in columnar and alveolar 
epithelial cells and its high expression at E20. Therefore, both PTN and its receptor RPTP / 
had the highest expression during the stage when alveolar epithelial cells proliferation and 
differentiation occur. The restricted temporal and spatial expression of these two genes suggests 
that PTN is a mediator of mesenchymal-epithelial interactions during fetal lung development,  
possibly reflecting their roles in fAEC II proliferation and differentiation. 
It is well known that epithelial-mesenchymal interaction is essential for normal growth, 
morphogenesis and cell differentiation in the developing lung (40). Signals from the mesenchymal 
cells determine the patterning of the epithelium as well as the differentiated phenotype of the 
epithelium. Removal of the mesenchyme from the developing lung impairs lung branching 
morphogenesis and stops the epithelium from proliferating and differentiating (41). During the late 
stage of fetal lung development, fAEC II differentiate from progenitor cells and further trans-
differentiate into AEC I. Many factors secreted from the mesenchyme have been identified to 
regulate fAEC II differentiation including FGF10 (23). Our current study identified PTN as an 
additional such factor.  
PTN increased fAEC II proliferation and inhibited fAEC II trans-differentiation. The 
regulation of cell proliferation is coupled with that of cell differentiation. The cells that enter 
differentiation pathway normally go into G0 phase and stop proliferating (15; 36; 45). The cell 
proliferation and differentiation are independent but well coupled processes that can be precisely 
regulated by many factors. In normal development, the progenitor cells generate enough cells for 
	

differentiation, and then exit from cell cycle and start to differentiate into mature cells (36). In 
myogenic precursor cells, this process is achieved by upregulating P21 which inhibits the cdk 
activities (45). Reversely, it has been demonstrated that the overexpression of the cell cycle 
protein, cyclin D1 blocks the terminal differentiation (33). Collectively, PTN may act as a link 
between fAEC II proliferation and differentiation. It may achieve this by keeping the fAEC II in a 
proliferating state and maintains its phenotype. Since coordinated cell proliferation and 
differentiation are essential for normal organogenesis. PTN may play an essential role in fetal 
lung development.  
Recently, PTN was found to play a role in epithelial-mesenchymal transition (EMT) (29). 
PTN-treated U373 epithelial cells exhibited fibroblast-like cells with elongated shape, increased 
cell migration and disappeared cell polarity. We found that PTN increased wound healing, 
possibly due to an increased cell migration. This is supported by the observation that PTN-treated 
fAEC II had fibroblast-like F-actin distribution on the edge of the wound area. Furthermore, 
canonical Wnt signaling pathway is important for the cancer cell invasion and migration (27). Our 
results showed that PTN activated the Wnt/-catenin signaling. The effect of PTN on fAEC II 
wound healing may also be partly due to the cell proliferation or migration.   
PTN has been identified as an important factor on renal branching morphogenesis (37). 
Glial-derived neurotrophic factor (GDNF), a peptide growth factor which is required for ureteric 
bud outgrowth, induces the branching in isolated ureteric bud explants at the presence of PTN. 
However, purified PTN alone also induces ureteric bud outgrowth. This result suggests that PTN 
is necessary for GDNF signaling. Additionally, using whole embryonic kidney organ culture, PTN 
induces the ureteric bud outgrowth. Similar to renal branching, the lung undergoes branching 
morphogenesis during the development. Knockdown of PTN expression decreased the number of 
terminal buds, indicating its role in lung branching morphogenesis. However, how PTN regulates 
lung branching morphogenesis remains to be determined.  
We found that PTN increased the tyrosine phosphorylation of -catenin in fAECII, 
resulting in -catenin accumulation in the nucleus and thus increase LEF/TCF transcriptional 
activity. Tyrosine phosphorylation of -catenin at Y654 and Y142 reduces the binding affinity of -
catenin to E-cadherin and -catenin, respectively (21; 31; 35). Several lines of evidence have 
demonstrated that tyrosine phosphorylation of -catenin abolishes adhesion and increase the 
transcription activity (30). Thus, PTN may act as a key regulator in switching the role of -catenin 
from cell adhesion to transcription. Since PTN enhanced TCF/LEF activity as assessed by the 
TOPflash assay, we, for the first time, integrated the PTN/RPTP / pathway with the canonical 
-catenin/LEF-TCF pathway.   
Wnt regulates lung morphogenesis through the canonical -catenin/LEF-TCF pathway 




the developing lung (8; 26). In the absence of Wnt signal, -catenin is phosphorylated at several 
serine-threonine sites by glycogen synthase kinase 3beta and casein kinase and is subsequently 
marked for proteasomal degradation (10; 30; 48). In the presence of Wnts, -catenin is stabilized 
and accumulates in the nucleus to activate the transcription of its downstream genes such as N-
myc, bone morphogenetic protein 4 and FGF. In U373 cells, PTN increases tyrosine 
phorphorylation of -catenin and releases -catenin from the membrane (29). However, 
subsequent -catenin nuclear accumulation is not reported. In the present studies, we observed 
that PTN not only increased tyrosine phosphorylation of β-catenin, but also resulted in the -
catenin nuclear translocation and the activation of TCF/LEF in fAEC II. Our results suggest that 
PTN may enhance the Wnt/-catenin signaling and thus regulate lung development. 
Both canonical Wnt and Notch signaling pathway is indispensable for stem and 
progenitor cell fate determination and subsequent differentiation during embryonic development 
and adult life (1; 6; 7; 11; 28). These two pathways are reciprocally regulated. Abolishment of Wnt 
signaling leads to instable notch activities during somitogenesis (2). These results suggested that 
Wnt pathway may act as an upstream regulator of Notch pathway. Dlk-1 is a ligand of Notch 
receptor. Another member of this family, Dll1 was identified as a direct target of TCF/LEF 
transcription factors (13; 18). The following evidence support that PTN/Wnt--catenin signaling 
pathways negatively regulate Dlk1 in fAEC II: (i) -catenin decreased Dlk1 promoter activity in a 
dose-dependent manner and the addition of PTN further reduced the Dlk1 promoter activity. 

GSK--catenin, a constitutively activated -catenin mutant, had more profound effects on the 
Dlk1 promoter activity. (ii) ChIP assay showed that -catenin bound to both TCF/LEF binding 
sites on the Dlk1 promoter and this binding was enhanced by Wnt3a. and (iii) Dlk1 was down-
regulated in Wnt3a- or LiCl-treated fAEC II. Together with the fact that PTN activated the Wnt 
signaling pathway, these results suggest a novel molecular link between Notch and Wnt signaling 
pathways during fetal lung development. 
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DEFICIENCY OF PTN RESULTS IN ABNORMAL LUNG DEVELOPMENT IN ADULT MICE 
 
4.1 Abstract 
 Pleiotrophin (PTN) is a heprin-binding cytokine which has multiple roles on cell 
proliferation, differentiation, and apoptosis. No in vivo studies have been carried out to investigate 
the role of PTN in fetal lung development. In this study, using PTN knockout (PTN-/-) and wild-
type (PTN+/+) mice, we examined the lung morphology and cell marker gene expression during 
lung development. The lung morphology had no significant difference between PTN-/- and PTN+/+ 
mice during the fetal and early postnatal stages. However, on postnatal day 15 and 35, the lungs 
of PTN-/- mice were less mature and developed than those of PTN+/+ mice of the same age. These 
lungs exhibited hyperplasia, which was accompanied with significantly smaller alveoli and thicker 
septa. In the adult stage, the mRNA expression of SP-A, B, and C, and CCSP all increased 
significantly, while P2X7R and T1- expression decreased, and -SMA expression was 
significantly higher in PTN-/- mouse lungs. Our data indicated that deprivation of PTN expression 
may slow lung maturation by arresting lung development at juvenile and adult, where alveolar 
epithelial type II cells were accumulated but failed to further differentiate into alveolar epithelial 
type I cells. Our data demonstrate for the first time that PTN may play an important role in 





 Pulmonary development is an important biological process. The lung originates from the 
foregut endoderm and develops by repeated bifurcal branching morphogenesis. The mammalian 
pulmonary system is among the latest organs to be mature functionally. During normal lung 
development, the mesenchymal-epithelial interactions play crucial roles in inducing the origination 
of the lung bud, promoting the lung branching morphogenesis, and stimulating epithelial 
differentiation. Signals from the mesenchyme are critical to induce the formation of the epithelium. 
Removing the mesenchyme from the embryonic lung rudiment impairs branching morphogenesis. 
The lung mesenchyme alone is sufficient to induce branching morphogenesis in non-lung 
epitheliums such as salivary gland (17) and embryonic trachea, whose mesenchyme has been 
removed (1; 34). On the other hand, epithelial cells also express and secrete growth factors to 
regulate the differentiation and proliferation of mesenchymal cells. The mesenchymal-epithelial 
interactions are mediated by many signaling molecules, such as transcription factors, growth 
factors, and extracellular matrix proteins. These factors include those secreted from 
mesenchymal cells, such as fibroblast growth factors (FGFs),  and their receptors, retinoid acid 
(RA), and Wnt proteins, and those expressed by epithelial cells, including vascular endothelial 
growth factors (VEGF), Platelet-derived growth factor (PDGF), and Sonic Hedgehog (Shh) (26). 
Previously, using cDNA microarray, we identified Pleitrophin (PTN) as a growth factor, that 
was differentially expressed during fetal lung development (31).  PTN is a highly conserved 
extracellular growth factor and shares 50% homology with Midkine (MK), the only other heparin 
binding cytokine in the family. The expression of PTN is precisely regulated during development.  
PTN is mainly located in the basement membrane of the developing epithelium and in 
mesenchymal tissues undergoing remodeling, suggesting that it may regulate cell differentiation 
and mesenchymal-epithelial interactions (19). In the adult stage, PTN expression is only 
restricted to central nervous system (18; 23). PTN has multiple functions. It regulates neurite 
outgrowth, plays an important role in neural and cancer development, enhances the cell 
proliferation and migration, and inhibits the apoptosis of various cells. Additionally, PTN has been 
implicated in epithelial-mesenchymal interactions during the organogenesis (15; 22). However, 
the role of PTN on fetal lung development is barely studied.   
We have previously shown that PTN is mainly located in the mesenchymal area surrounding 
the developing epithelium, and its receptor, protein receptor tyrosine phosphatase / (RPTP/), 
is in the airway and developing alveolar epithelium, indicating that PTN may play an important 
role in the mesenchymal-epithelium interaction during fetal lung development (32). Additionally, 
PTN is able to increase the proliferation and inhibit the differentiation of primary cultured fetal lung 
epithelial cells. However, no in vivo studies have been carried out to investigate the role of PTN in 
normal lung development. 
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 Several research groups have used PTN knockout (PTN-/-) mice to study PTN functions. 
The PTN-/- mice are fertile and appear to be anatomically normal. However, mice deficient of PTN 
expression exhibit enhanced hippocampal long-term potentiation (2). Deficiency of PTN results in 
increased proliferation rate of neuronal stem cells in the adult mouse cerebral cortex (11). 
Consistently, exogenous PTN reduces the neuronal stem cell proliferation through inhibiting the 
expression of FGF-2 and promotes cell differentiation (11). However, whether PTN-/- mice have 
normal lung development is not known.  
In this study, we used PTN-/- mice to investigate the role of PTN in fetal lung development. 
Using Real-time PCR and Western Blot, we examined cell marker gene expression to monitor cell 
differentiation during development. We also investigated the morphological changes of the 
developing lung using morphometric analysis. Our study is the first report to demonstrate the role 




4.3 Material and Methods 
4.3.1 Pleiotrophin Knockout Mice 
 Mice deficient in PTN gene (a kind gift from Dr. T. Muramatsu) were generated as 
described (24). To achieve a genetic identity, PTN+/- mice were backcrossed with C57BL/6J mice 
for several generations (21; 37). The offspring’s genotype was determined by PCR using the 
genomic DNA isolated from a part of the ear. PTN-/- and PTN+/+ mice were generated by mating 
two PTN +/- mice with each other. Timed pregnant PTN-/- and PTN+/+ mice were obtained by 
mating a male and a female PTN-/- or PTN+/+ mouse. The day when a vaginal plug was observed 
was defined as embryonic day 0.5.  
4.3.2 Tissue section preparation  
 The fetal mouse lungs were prepared as described (31). Briefly, timed pregnant mice 
were killed by carbon-dioxide. The fetuses were removed from the uterus to harvest the fetal 
lungs. The isolated lungs were immediately fixed in 4% formaldehyde in PBS for 24 hours. 
Postnatal day 1 and 7 mice were killed by carbon-dioxide, and the lungs were separated and 
fixed. Postnatal day 15 and adult mice were killed by injection of anesthetic (40 mg Ketamine and 
8 mg Xylazine per 1 kg animals). The lungs were perfused with Hank’s Balanced Salt Solution 
(HBSS) (Invitrogen, Carlsbad, CA) and fixed by instilling 4% formaldehyde-PBS into the trachea 
under a hydrostatic pressure of 20 cm for 10 min. Then, the lungs were separated and placed in 
4% formaldehyde-PBS for additional 24 hours. The fixed lungs were washed in PBS, dehydrated 
in series of different concentrations of ethanol and xylene, and paraffin-embedded (60°C). The 
lung sections were cut (4 	m thickness) and placed on polysine glass slides. Hematoxyline and 
eosin staining was performed to study the lung morphology. 
4.3.3 Morphometric Analysis 
 The morphometric analysis was carried out by examining 15 fields selected from 3 
sections for each treatment group. To eliminate regional differences, at least one field was taken 
from each of the following three regions: the upper lobes, the right lower lobe and the left lower 
lobe. The alveolarization was assessed by measuring mean linear intercept (MLI), the diameter 
and lumen size of the alveoli. The MLI was obtained by drawing 4 lines across the lung section 
(two diagonal lines, one horizontal line and one vertical line across the whole field, the areas with 
alveolar sacs and bronchioles were avoided) and dividing the length of the line by the number of 
intercepts encountered. For alveolar diameter and lumen size, and septa thickness, the slides 
were examined at 800X magnification. The diameter of the alveoli was obtained by measuring the 
longest diameter of 500 randomly selected, non-overlapping alveoli for each treatment group. The 
septa thickness was obtained by randomly measuring the thickness of 4 septa of each alveoli and 
at least 15 alveoli per fields using the Image J software. The alveolar lumen size was evaluated 
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using Image J by measuring the closed area of all the alveoli in each field. All the images were 
analyzed blindly.  
4.3.4 Real-time PCR 
Total RNAs from PTN-/- and PTN+/+ mouse lungs were isolated using TRI reagent. Genomic 
DNA contamination was removed with RNase-freeTM DNase (Ambion Inc., Austin, TX). 1 	g total 
RNAs were reverse-transcribed into cDNA using oligo dT and random hexamers (promega, 
Madison, WI) and M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA). The primers for real-
time PCR were designed using Primer Express® software (Applied Biosystems, Foster City, CA): 
T1- forward: 5’-ACCGTGCCAGTGTTGTTCTG-3’, reverse: 5’-
AGCACCTGTGGTTGTTATTTTGT-3’; SP-A forward: 5’-GAGGAGCTTCAGACTGCACTC-3’, 
reverse: 5’-AGACTTTATCCCCCACTGACAG-3’; SP-B forward: 5’-
CTGCTTCCTACCCTCTGCTG-3’, reverse: 5’-CTTGGCACAGGTCATTAGCTC-3’; SP-C forward: 
5’-ATGGACATGAGTAGCAAAGAGGT-3’, reverse: 5’-CACGATGAGAAGGCGTTTGAG-3’; CCSP 
forward: 5’-ATGAAGATCGCCATCACAATCAC-3’, reverse: 5’-GGATGCCACATAACCAGACTCT-
3’; Midkine forward: 5’-GAAGAAGGCGCGGTACAATG-3’, reverse: 5’-
GAGGTGCAGGGCTTAGTCA-3’; 18S forward: 5’-ATTGCTCAATCTCGGGTGGCTG-3’ and 
reverse: 5’-CGTTCTTAGTTGGTGGAGCGATTTG 3’. Real-time PCR was performed on 7900HT 
Fast Real-Time PCR System using SYBR Green I detection (Eurogentec, San Diego, CA) as 
previously described (33). After the amplification, a dissociation curve was generated to check the 
specificity of the amplification. The data were normalized to 18S rRNA.  
4.3.5 Western Blot 
 The lung tissues were homogenized in M-PER lysis buffer (Pierce, Rockford, IL) on ice. 
Protein concentration was determined using the DC protein assay kit (Bio-Rad, Hercules, CA). 
Total proteins were separated by 10% SDS-PAGE and then transferred onto a nitrocellulose 
membrane. The blot was stained by Ponceau S to check transfer efficiency. The membrane was 
blocked with 5% dry milk in Tris-buffered saline for 1 hour, washed with Tris-buffered saline 
containing 0.05% Tween 20, and incubated with mouse anti -SMA (1:2000, Sigma, St. Louis, 
MO), rabbit anti-vimentin (1:500, Abcam, Cambridge, MA) or rabbit anti--actin antibodies 
(1:1,000 dilution; Bio-Rad, Hercules, CA) overnight at 4°C. The membrane was washed again 
and incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (1:2,000, 
Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 hour. Finally, the membrane was 
developed with enhanced chemiluminescence reagents (Amersham Biosciences, Piscataway, 





 The lungs sections were deparaffinized in xylene, and rehydrated in grade ethanol. After 
being washed in PBS, the sections were incubated in 3% peroxide for 10 min to remove the 
endogenous preoxidase, permeabilized with 0.3% Triton X-100 in PBS for 20 min, kept in 20 mM 
citrate buffer (pH 6.0) for 5 min for antigen retrieval and blocked with 10% FBS in PBS for 1 hour. 
Then the slides were incubated with primary antibodies overnight at 4°C, followed by 1 hour 
incubation with secondary antibodies. After rinse, the slides were further incubated with fresh 
ABC reagent (Vector Laboratories, Burlingame, CA) for 30 min and then developed in DAB 
reagent until desire staining was observed. Finally the slides were counter-stained with 
Hematoxylin (Vector Laboratories, Burlingame, CA) for 1 min, mounted with permanent anti-fade 




4.4.1 PTN-/- mouse lung was less developed in adult   
The PTN-/- mice were fertile and had no obvious physiological abnormalities. The lung to 
body weight of the PTN-/- mice were slightly lower but not significantly different compared to the 
PTN+/+ mice (Fig.IV.1).  
         
Fig.IV.1. PTN-/- mice have slightly decreased lung to body weight. The lungs were collected from 
4 to 6 months old PTN-/- and PTN+/+ mice, and the lung weight to body weight were measured 


























To examine the morphological changes during development, we collected the lungs from 
PTN-/- and PTN+/+ mice at embryonic day 14.5, and 17.5 (E14.5 and E17.5), postnatal day 1, 7, 
15 and 35 (P1, P7, P15, and P35). The E14.5 and E17.5 lungs of PTN-/- mice had no significantly 
difference from those of PTN+/+ mice (Fig.II.2 panel A and B). At the early postnatal stages (P1 
and P7), still no difference was observed between PTN+/+ and PTN-/- mice. However, there were 
consistent and appreciable differences between lung sections of PTN+/+ and PTN-/- mice on P15 
and P35. In both age groups, alveolar septa from PTN-/- mice were thicker than those from age-
matched PTN+/+ mice (Fig.IV.2A). On average, in the PTN-/- mice, the septa thickness increased 
more than 100%. The average alveolar lumen size decreased ~ 50% and alveolar diameter 
diminished ~30% compared with the PTN+/+ mice (Fig.IV.2B). In accordance with these data, the 
mean linear intercept of the PTN-/- mice decreased ~20% in P35 (Fig.IV.2B). The thickened and 
hypercellular alveolar septa in PTN-/- mice appeared to be less mature or developed and less 
inflated than those in PTN+/+ mice of the same age. One P35 PTN-/- mouse had moderately 
increased numbers of monocytes and macrophages in alveolar lumens, but this was not a 
change seen consistently between PTN+/+ and PTN-/- animals. No consistent pathological 























       
           
Fig.IV.2. PTN-/- mice have abnormal lung morphology during the alveolar stage. The lungs were 
collected at embryonic day 14.5, 17.5 (E14.5 and E17.5), postnatal day 15 and 35 (P15 to P35) 
from PTN-/- and PTN+/+ mouse lungs. (A) Representative hemotoxylin-eosin stained lung section 
from different developing stages (Magnification 200X, scale bar: 100 µm). PTN-/- mice showed 
less developed saccules marked with hypercellular and thickened septa on P15 and P35. (B) 
Morphometric assay of the P15 and P35 lungs in PTN-/- and PTN+/+ mice. The septa thickness, 
alveolar lumen size, maximal diameter of the alveoli, and mean linear intercept were assessed.  
Significant changes were observed in most of these parameters in P35 PTN -/- mice. Data are 
means ± S.E. (*P<0.001, n=3 mice from different litters). 
 
4.4.2 Cell marker gene expression in PTN -/- mice 
To evaluate the differentiation of epithelial and mesenchymal cells in PTN-/- mouse lungs, real-
time PCR and western blot were carried out to examine the cell marker gene expression.  
AEC II differentiation was evaluated according to the expression of Surfactant proteins. The 
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Fig.IV.4. AEC I marker expression in PTN-/- and PTN+/+ mice. Total mRNAs were collected from 
PTN-/- and PTN+/+ mouse lungs at different developmental stages, and reverse-transcripted into 
cDNA. The mRNA expression of T1 and P2X7R were determined using Real-time PCR. The 
results were normalized to 18S rRNA and were expressed as a ratio to P1 PTN-/- mice. Data are 
means ± S.E., * P<0.01 v.s. PTN+/+ at the same age, n=2 biological replications X 2 technical 
replications for E 14.5 and E17.5, n=2 technical replications for E 15.5, n=3 biological replications 
X 2 technical replications for the others. 
 
The expression of Clara cell 10KD protein (CC10), a Clara cell specific marker, was 
increased ~2.5 fold in P15 and more than 6 fold in P35 PTN-/- mice (Fig.IV.5).  
 
Fig.IV.5. mRNA expression of Clara cell marker in PTN-/- and PTN+/+ mice. PTN-/- and PTN+/+ 
mouse lungs were collected at different developmental stages. Total RNA were extracted and 
reverse-transcripted into cDNA. Real-time PCR was used to quantitate the mRNA expression of 
CC10. 18S rRNA was used as an internal control. Data were normalized to P1 PTN-/- mice and 
expressed as means ± S.E., * P<0.01 v.s. PTN+/+ at the same age, n=2 biological replications X 2 
technical replications for E 14.5 and E17.5, n=2 technical replications for E 15.5, and n=3 
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The protein expression of alpha smooth muscle actin (-SMA), a myofibroblast marker, 
significantly increased in P15 and P35 PTN-/- mice (Fig.IV.6). Vimentin, a mesenchymal cell 
marker, was not different between PTN-/- and PTN+/+ mice (Fig.IV.6).  
 
Fig.IV.6. Mesenchymal cell marker expression during the fetal lung development. Total proteins 
were collected from P15 and P35 PTN-/- and PTN+/+ mouse lungs. Western blot were carried out 
using antibodies against -SMA and Vimentin. -actin was used as a loading control. (A) The 
representative protein bands were shown. (B) The densities of the bands were measured and 
normalized to -actin. Data are mean ± S.E. (n=2 for E14.5 and E17.5, n=3 for the others). 
 
The mRNA expression of MK, the only other member of the PTN family, was nearly double 
in E14.5 and P35 PTN-/- mouse lung, but had no significant difference between PTN-/- and PTN+/+ 
lungs at the other stages (Fig.IV.7), indicating that MK and PTN may at least have some distinct 
roles during fetal lung development.   
5&-6 *
" $

























































Fig.IV.7. Real-time PCR quantitates the mRNA expression of Midkine in PTN-/- and PTN+/+ mouse 
lung during development. Total mRNA were extracted from PTN-/- and PTN+/+ mouse lungs at 
different development stages, and reverse-transcripted into cDNA. Real-time PCR were carried 
out to measure the mRNA expression of CC10. The results were normalized to 18S and were 
expressed as a ratio to P1 PTN-/- mice. Data are mean ± S.E., * P<0.01 v.s. PTN+/+ at the same 
age, n=2 biological replications X 2 technical replications for E 14.5 and E17.5, n=2 technical 
replications for E 15.5, n=3 biological replications X 2 technical replications for the others. 
 
4.5 Discussion 
 In this study, we compared fetal lung development between PTN-/- and PTN+/+ mice. We 
have previously shown that PTN is highly expressed at the late stage of fetal lung development 
and reaches a peak level shortly after birth. In adult, PTN expression is very low (18). PTN-/- mice 
showed no abnormalities in lung morphology and cell marker expression at the early stages of 
development including the stage when PTN has the highest expression level. However, 
consistent differences were observed on P15 and P35 when PTN expression was low. At these 
stages, PTN-/- lungs were less mature and developed; the sacs showed thickened and 
hypercellular alveolar septa. The differences caused by PTN deficiency at the early stage are 
probably accumulated and magnified at the late developing stage. This phenomenon was 
observed previously. For example, the rats that had transient in utero disruption of cystic fibrosis 
conductance transmembrane regulator (CFTR) on gestational day 16 did not result in abnormal 
lung function until 30 days of age with symptom progressed as aged (12). Exposing neonatal 
mice to oxygen impairs lung development, and results in enlarged airway and alveolar size in 
adult (35).Several adult onset diseases can also result from changes in the fetal environment, 





























 /3/  &3&


 At the alveolar stage, the lung is characterized by repeated growth and separation of 
thousands of alveoli, which dramatically increases the surface area for gas exchange. From our 
study, the thicker septa and smaller alveolar size observed in PTN-/- mice indicated that PTN may 
have an important role in lung alveolarization. In the PTN-/- mouse lung, the saccules were 
hypercellular with dramatically increased lung parenchyma density and thickened septa. The 
normal development of the saccules seemed perturbed. The lung lacked the single capillary layer 
septa which are typical of the lungs at the adult stage. Thickened septa can be an indicator of 
underdeveloped lungs and are related to several lung diseases, such as interstitial lung disease 
with fibrosis, idiopathic pulmonary fibrosis (IPF) and pulmonary hyperplasia (13; 29; 36). Thick 
septa and pulmonary hyperplasia are also observed in mice treated with growth factors such as 
Keratinocyte growth factor (KGF) or inflammatory cytokines such as IL-1 (5; 30). Interestingly, 
inactivating glycogen synthase kinase-3(beta) (GSK-3), a key inhibitor for Wnt/-catenin 
pathway, also induces airway smooth muscle hyperplasia in asthma (4). Since PTN is related to 
the Wnt/-catenin pathway, it provides a possible regulatory mechanism of PTN. Our data 
suggest that PTN is required, at least in part, for the alveolarization of the lung through altering 
proliferation and differentiation of mutiple cell types.  
 AEC I and AEC II are essential for normal lung function. A significantly increased 
expression of SP-A, SP-B, SP-C and CC10 mRNA in adult PTN-/- mouse lung indicates that more 
AEC II and Clara cells may be accumulated. However, additional evidence is needed to elucidate 
whether this is due to an increased proliferation of these cells, a simply increased marker gene 
expression or an increased differentiation from precursor cells. These AEC II appear to fail to 
further trans-differentiate into squamous cells as seen from the decreased mRNA expression of 
AEC I marker, T1- and P2X7R. These results seem to controdict previous in vitro findings that 
PTN promotes fetal AEC II proliferation and arrests the fetal AEC II trans-differentiation into AEC I 
cells in primary cell culture (32). However, in comparison with cell culture, the lung tissue has a 
much more complex environment, which includes multiple interactions among different cells and 
extracellular matrix. Additionally, PTN acts on various lung cells, including epithelial cells, 
endothelial cells and mesenchymal cells (8; 25).  
Beside its effects on epithelial cells, PTN also influences the differention and proliferation of 
mesenchymal cell through a direct or indirect mechanism. -SMA is a marker of myofibroblast. It 
is normally expressed along trachea, proximal airway and large vascular tubes. In the distal lung, 
-SMA is expressed by interstitial myofibroblasts in the septa. The function of smooth muscle 
cells is to control the contraction and proliferation, and to synthesize matrix proteins, including 
collagen and elastin. Abnormal expression of -SMA is associated with some lung diseases, such 
as lymphangioleiomyomatosis (LAM) (16; 28), and asthma (3; 6). In P15 and P35 PTN-/- mouse 
lung, -SMA expression was significantly increased. Smooth muscle cell hyperplasia was also 
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observed in the conducting airways. The enhanced proliferation of myofibroblast in the interstitial 
tissue may partly contribute to the increased septa thickness.  
PTN shares some functional redundancy with MK and they may partly compensate for each 
other when one of them is deficient. In MK knockout mice, PTN expression was dramatically up-
regulated in several organs (10), including spinal cord, dorsal root ganglia, eye, heart, aorta, 
bladder, and urethra. However, in the brain, bone marrow and lung, PTN expression was not 
increased in MK knockout mice, suggesting that PTN and MK may play distinct roles in these 
organs. PTN-/- mice do show significant abnormality in the brain and bone development (11; 14). 
Increased proliferation and decreased differentiation of neural stem cells were observed in the 
developing PTN-/- mice brain (11). Similarly, PTN knockout decelerates the growth of the weight-
bearing bone and inhibits bone remodeling (14). PTN and MK may also have distinct roles in the 
lung. First, our results showed that MK expression did not change dramatically in PTN-/- mice 
during lung development, except E14.5 and P35. Second, MK and PTN have distinct expression 
pattern in the developing lung: MK is mainly expressed in the developing epithelial cells, while 
PTN is located to the base membrane (19). Third, MK expression is high in embryonic stage and 
decreases after embryonic day 16.5; but PTN level is highest at early postnatal stage (19). Taken 
together, PTN may not be compensated by the increased expression of MK in the lung, indicating 
that the roles of MK and PTN in the lung are different. This may explain why PTN-/- mice have 
more abnormalities in the lungs than some of the other organs. 
In summary, PTN signaling appears to be essential to the late stage of the fetal lung 
development, especially for saccular structure formation and alveolarization. This may be due to 
PTN’s effect on epithelial and mesenchymal cells. PTN deficiency increases proliferation of many 
lung cells, including Clara cells, AEC II and myofibroblasts, and inhibits the further trans-
differentiation of AEC II into AEC I.  
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 P2X7 receptor (P2X7R) is a purinergic ion-channel receptor. Previously, we found that 
P2X7R could activate the surfactant secretion in AEC II by releasing ATP from AEC I. In this 
study, we determined whether miRNA regulates P2X7R-mediated surfactant secretion. We first 
used a dual-luciferase assay to screen the regulation of P2X7R 3’-UTR activity by miR-150, miR-
186, miR-204 and miR-211. We found that miR-150 is a regulator of P2X7R in lung epithelial 
cells. The miR-150 regulation could be disrupted by site mutation of mature miR-150 or mutation 
of P2X7R 3’-UTR at miR-150 binding sites. Adenovirus expressing miR-150 significantly reduced 
the P2X7R protein expression in E10 cells. Furthermore, pre-treatment of E10 cells with 
adenovirus expressing miR-150 disrupted the surfactant secretion induced by E10 cell 
conditioned media. Our study is the first of its kind to demonstrate that miR-150 regulates P2X7R-
mediated surfactant secretion.  





P2X7 receptors (P2X7R) belongs to the P2X receptor family which are plasma membrane 
ligand-gated ion channels activated by ATP (16). P2X7R shares many similar properties with 
other P2X receptors. The binding of ATP causes P2X receptors to open within millisecond and 
stimulates cell depolarization by an influx of cationic ions, including Na+, K+ (normally through a 
Ca2+ activated K+ channel), and Ca2+ ions (11). P2X7R was initially identified as a unique ATP-
gated channel P2Z due to its low degree of structural homology compared with other family 
members. P2X7R has a less conserved and unusually long COOH terminus, which forms a large 
non-selective pore permeable to small molecules such as YO-PRO, Cl-, Lucifer yellow and 
ethidium bromide (EB) (32). In comparation with other P2X receptors, the activation of P2X7R 
needs at least 10-fold higher ATP concentration due to its low affinity for ATP, but the 
desensitization of P2X7R is much slower compared to the other P2X receptors. Another unique 
property of P2X7R is that it mediates a reversible plasma membrane permeabilization. P2X7R 
activation also enhances the release of endogenous cytokines involved in the immune-response, 
such as interleukin-1beta (IL-1) (25). However, sustained stimulation of P2X7R leads to 
membrane blebbing and programmed cell death (12; 30). 
P2X7R mediates ATP release as well, which was first observed in rat astrocytes after 
stimulation with the P2X7R agonist, ([2'-3'-O-(4-Benzoyl-benzoyl) adenosine 5'-triphosphate or 
BzATP (2). Suadicani et. al further confirmed that P2X7R, but not Cx43 hemichannels mediated 
ATP release in human and mouse astrocytes (29). We have found that BzATP increases ATP 
release from alveolar epithelial cells via P2X7R (23). 
The distal lung epithelium is lined with alveolar epithelial type I and type II cells (AEC I and 
AEC II). AEC I cover about 95% and AEC II occupy less than 5% of the alveolar surface area 
(22). AEC I are large squamous cells responsible for gas exchange, fluid transport and protection 
against oxidative stress (5; 6; 15; 27). AEC II are cuboidal and normally located in the corners of 
alveoli. AEC II also synthesize and secrete pulmonary surfactant, a lipoprotein complex that 
spreads on the surface of alveoli to form a thin lining layer and reduces the surface tension. 
Insufficient amount of pulmonary surfactant leads to abnormal lung functions(14; 34). 
The molecular mechanism that regulates surfactant secretion is of great interest. The 
secretion of surfactant from AEC II can be regulated by many molecules, such as intracellular 
Ca2+, P2Y2 receptor agonists (ATP and UTP), adenosine, platelet activating factor, and IL-1 etc 
(1). Of all these molecules, extracellular ATP is the most effective endogenous regulator. Through 
binding to P2Y2 receptors on the AEC II plasma membrane, ATP activates phospholipase C, 
which generates diacylglycerol (DAG) and inositol trisphosphate (IP3), and subsequently activates 
protein kinase C (PKC) and increases cytoplasmic Ca2+ concentration (1).  
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MicroRNAs (miRNA) are naturally existed small non-coding RNAs that either cleave specific 
mRNAs or inhibit mRNA translation through complementary base pairing and subsequently 
silence target genes (19). They regulate diverse cellular processes such as proliferation, 
differentiation, apoptosis, and exocytosis. The processing of miRNA needs both Drosha and 
Dicer (31). In animals, miRNAs are first transcribed as primary transcripts (pri-miRNAs). The pri-
miRNAs are cleaved by Drosha in the nucleus to release the loop structure and generate ~70nt 
pre-miRNAs (18). Pre-miRNAs are associated with Exportin 5-RanGTP, exported out of the 
nucleus and cleaved by Dicer in cytoplasm to yield 21-23 nt long mature miRNA (20; 36). One 
strand of miRNA is then loaded into the RNA-induced silencing component (RISC) (26). In 
mammals, the mature miRNA normally binds to the target mRNA with non-perfect base pairing 
and subsequently suppresses the mRNA translation.  
MiR-150 is a miRNA highly expressed in the tumour cells surrounding the proliferation 
centres in the bone marrow and lymphoid tissues (35; 37). MiR-150 is also present in mature B 
and T cells. It blocks B cell development by silencing the expression of c-Myb (35). Recently, 
miR-150 and miR-186 are identified as potential miRNAs that target to P2X7R (38). However, 
whether these miRNAs regulate the P2X7R-mediated surfactant secretion is not known.  
P2X7R is broadly expressed in multiple mammalian cells, including epithelial cells, 
endothelial cells, fibroblasts, and macrophages. P2X7R is specifically expressed in AEC I (8). Our 
preliminary studies have shown that the activation of P2X7R in AEC I stimulates surfactant 
secretion in AEC II (23).   
In our study, we first used dual-luciferase assay to screen the possible miRNAs that regulate 
P2X7R expression. We further determined that the miR-150 inhibited endogenous P2X7R protein 
expression in lung cells. Then we characterized miR-150 expression in different organs and lung 
epithelial cells. Finally, we examined the effect of miR-150 in P2X7R-mediated surfactant 
secretion in primary cultured AEC II.  
5.3 Materials and Methods 
5.3.1 Cell Culture 
E10 cell line was kindly provided by Dr. Mary Williams (Boston University). It was originally 
derived from explants of BALB/c female mouse lung and has AEC I characters. E10 cells were 
maintained in CMRL 1066 medium supplied with10% FBS and 0.5 mM L-glutamine. R3/1 cell is 
another AEC cell line and was kindly provided by Dr. Roland Koslowski (Dresden University of 
Technology, Germany). R3/1 cells were cultured in F12 medium supplied with 10% FBS. A549 is 
a human lung carcinoma cell line and was obtained from ATCC (Manassas, VA). A549 cells were 




5.3.2 miRNA viral vector construction 
The pENTR/CMV-EGFP-pri-miRNA vector containing the primary transcript of human 
miRNA (pri-miRNA) was constructed as described previously (4; 13). Briefly, the pri-miRNA 
fragment (mature miRNA plus 200 base pairs at each end) was amplified from human genomic 
DNA (Clontech, Mountain View, CA) using primers listed in Table 1. The pri-miRNA fragment was 
digested with XhoI and EcoRI or BsaI, gel-purified and inserted into a modified pENTR/CMV-
EGFP (Invitrogen, Carlsbad, CA) plasmid between enhanced green fluorescence protein stop 
coden and SV40 poly (A) terminal sequences. A plasmid that only expresses EGFP was used as 
a control vector. 
The mutated miR-150 expression vector, pENTR/CMV-EGFP-pri-miRNA-150mut was 
constructed using overlapping PCR as shown in Fig.V.1. Two primers containing mutated mature 
miR-150 (miR-150mut Foward and reverse primers) were designed (Table 1). First, fragment 1 
and fragment 2 were amplified from full length pri-miR-150 using primer pair miR-150 Foward/ 
miR-150mut Reverse and miR-150 Reveres/miR-150mut Foward. Then a second PCR was 
carried out using fragment 1 and fragment 2 as template and miR-150 forward and reverse 
primers. This PCR generated a pri-miR-150mut sequence which mutated the mature miR-150 
from TTGGGAG to TTCCCAG. This pri-miR-150mut fragment was digested with XhoI and EcoRI 
and inserted into the pENTR/CMV-EGFP vectors as described above.  
5.3.3 3’-UTR reporter vector construction 
To construct the P2X7R 3’-UTR reporter vector, the full length P2X7R 3’-UTR sequence (23 
to 1023) was amplified from human genomic DNA using the primers listed in Table 1. The 
amplified DNA fragment was digested using XbaI and PspOMI and inserted into the pRL-TK 
vector (Promega, Madison, WI), which contains a Renilla luciferase gene.  
For the truncated P2X7R 3’-UTR which contain miR-150 binding sites or mutations, 2 pmol 
each of the two primers (Table 1) were annealed in 30 µl reaction system (0.1 M NaCl) for 30 min 
at room temperature, which results in a double-stranded fragment with sticky ends at both sides. 
The fragment was directly inserted into the pRL-TK vectors. The generated mutation vector of 









Table.V.1 Primers for pri-miRNA expression vector and P2X7R 3’-UTR reporter vector. 

































































The restriction enzyme sites were underlined, the mutation sites were italic.  
 
5.3.4 Dual-luciferase assay 
E10 cells (8X104) were seeded in each well of 96-well plate. After 24 hours, 15 ng of 3’-UTR 
reporter vectors and 170 ng of miRNA expressing plasmids were co-transfected into E10 cells 
together with 15 ng of pGL-3 using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). The pGL-3 
expresses firefly luciferase and was used as a transfection control, Two days after transfection, 
the cells were harvested. The luciferase activities were determined using the Dual-Luciferase® 




Fig.V.1 Overlapping PCR constructs the pri
fragments were generated using pri
150mutR and miR-150mutF/miR
and fragment 2 as template and miR
 
5.3.5 Adenovirus production
The miRNA adenoviruses were produced as described 
sequences were transferred from pENTR/CMV
recombinant reaction using Gateway technology following the manufacturer’s instructions 
(Invitrogen, Carlsbad, CA). The plasmid from the positive clone was digested with PacI, purified 
using MinElute PCR purification kit (Qiagen, Valencia, CA)
cell line with Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). The adenovirus
cells were harvested, and the generated virus was used to amplify the viral stock. The titer was
determined by counting the 
5.3.6 Western Blot 
 E10 cells were tranduced with different doses of miR
adenoviruses for 4 days. Adenoviruses which only express GFP protein were used as a control. 
The cells were collected and lyzed in M
Rockford, IL) on ice. The protein concentration was determined using the Dc protein assay kit 
(Bio-Rad, Hercules, CA). Same amounts of proteins were separated by 10% SDS
transferred onto a nitrocellu
efficiency. The membrane was blocked with 5% dry milk in Tris
Tween 20 (TTBS) for 1 hour, incubated with rabbit anti
Louis, MO) or mouse anti-
After being washed, the membrane was incubated with horseradish peroxidase
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rabbit or anti-mouse IgG (1:2,000) for 1 hour. Finally, the membrane was developed with 
SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and exposed to X-ray 
film. 
5.3.7 Real-time PCR 
The cells or tissues were harvested and lyzed in the Lysis/Binding Buffer (Ambion Inc, 
Austin, TX). Total RNAs were isolated using the mirVanaTM miRNA Isolation Kit (Ambion Inc, 
Austin, TX) according to the manufacturer’s instructions. RNase-freeTM DNase (Ambion Inc., 
Austin, TX) was used to remove the genomic DNA contamination. The RNAs were reverse-
transcribed into cDNA using oligo dT and random hexamers (Promega, Madison, WI) and M-MLV 
reverse transcriptase (Invitrogen, Carlsbad, CA). The primers for real-time PCR were designed 
using Primer Express® software (Applied Biosystems, Foster City, CA). P2X7R: forward, 5’- 
ACCGTGCCAGTGTTGTTCTG-3’, and reverse, 5’-AGCACCTGTGGTTGTTATTTTGT-3’; 18S 
rRNA: forward, 5’-ATTGCTCAATCTCGGGTGGCTG-3’ and reverse, 5’- 
CGTTCTTAGTTGGTGGAGCGATTTG-3’.  Real-time PCR was performed on 7500HT Fast Real-
Time PCR System using SYBR Green I detection (Eurogentec, San Diego, CA) as previously 
described (33). After the amplification, a dissociation curve was generated to check the specificity 
of the amplification. 18S rRNA was used as an internal control.  
The real-time for miR-150 was carried out as described (28). 5 	g of total RNA was 
polyadenylated using A-Plus™ Poly (A) Polymerase tailing kit (Epicentre Biotechnologies, 
Madison, WI) as described in the manufacture’s instruction. The tailed RNA was purified using 
1:1 phenol/Chloroform and precipitated with 75% ethonal. One 	g poly(A) tailed RNA was 
reverse-transcribed into cDNA using oligo dT primers by M-MLV reverse transcriptase 
(Invitrogen, Carlsbad, CA). The target mature miRNA sequence (5’- 
CTGGTACAGGCCTGGGGGACAG-3’) was used as the forward PCR primer and a universal 
primer (5’- GCGAGCACAGAATTAATACGACTCAC-3’) was used as the reverse primer. Real-
time PCR was performed as described above. U2 small RNA was used to normalize the data.  
5.3.8 AEC II isolation 
 AEC II were isolated from Male Sprague-Dawley rats (180-200g) as previously described 
(3). Briefly, the lung was perfused, lavaged, and digested with elastase (3 units/ml) at 37°C. 
Then, the lung were chopped with a Mcllwain tissue chopper (Brinkmann, Westbury, NY), and the 
cell suspension was further digested with 100 ng/ml DNase I and filtered through 160- and 37-	m 
nylon mesh once and 15-	m nylon mesh twice. The cells were seeded on rat IgG-coated plates 
twice for 45 and 30 min to remove macrophages. The final AEC II preparation normally has a 
purity of 90% and a viability of over 98%. AEC II were seeded onto 35-mm tissue culture-treated 




5.3.9 Surfactant Secretion 
 E10 cells were cultured in DMEM supplied with 10% FBS and transduced with 100 
Multiplicity of Infection (MOI= ratio of infectious virus particles to cells) adenoviruses for 4 days. 
The cells were then treated with 25 µM BzATP for 2 hours. The media were collected as 
conditional media. The freshly isolated AEC II (1 X 106) were cultured overnight in the presence 
of [3H] choline (0.6 µCi/106 cells). AEC II were incubated with or without the conditional media for 
2 hours. Lipids in media and cells were extracted and surfactant secretion was performed 
according to Chintagari et al. (10). Surfactant secretion (%) was expressed as (dpm in 
medium/dpm in medium and cells) x100. A stimulation index was expressed as a ratio of 
stimulated secretion with a conditioned media to basal secretion without conditioned media. 
5.4 Resutls 
5.4.1 P2X7R is a direct target of miR-150 
 Based on the TargetScanHuman (V5.1) Target Database, there is only one conserved 
binding site of miR-204 and miR-211 on P2X7R 3’-UTR among mammals. Recently, miR-150 and 
miR-186 were reported as miRNAs that potentially target to P2X7R (38). To identify miRNAs that 
target P2X7R in alveolar epithelial cells, we constructed miRNA expression vectors 
(pENTR/CMV-EGFP-primiRNA) for miR-150, miR-186, miR-204 and miR-211. The pENTR/CMV-
EGFP vector which only expresses EGFP was used as a control vector. Then we attached the full 
length 3’-UTR of P2X7R (23-1023) to Renilla luciferase (RL) gene. The resulted plasmid, RL-
P2X7R, was co-transfected with a miRNA expression vector into E10 cells (a mouse AEC I cell 
line). As shown in Fig.V.2A, the pENTR expressing miR-150 significantly inhibited RL-P2X7R 
activity. However, all the other miRNAs had no effects on the RL-P2X7R activity. To assess the 
specificity of miR-150 regulation, we also constructed a plasmid which expressed a mutated miR-
150. The mutation of miR-150 lost its inhibitory effect on RL-P2X7R activity (Fig.V.2B). 
Similar inhibitory of RL-P2X7R by miR-150 was also observed in A549, a carcinoma human 
alveolar epithelial cell line, and R3/1, a rat lung type I cell line (Fig.V.2C). Our results 





Fig.V.2 Screening of miRNAs regulating P2X7R 3’-UTR reporter activity. (A) To screen the 
miRNAs targeted to P2X7R, 170 ng  pENTR/CMV-EGFP-primiRNA (Control vector, miR-150, 
miR-186, miR-204, or miR-211) were transfected into E10 cells together with 15 ng full-length 
P2X7R 3’UTR Renilla reporter construct (RL-P2X7R) and 15 ng pGL3 plasmid. 48 hours after 
transfection, the cells were haversted and the dual-luciferase activities were measured. (B) To 
examine the specificity of the miR-150 regulation of P2X7R 3’-UTR, mutation plasmids of miR-
150 (miR-150mut) was constructed. 15 ng RL-P2X7R and 170 ng pENTR/CMV-EGFP-miR-150 
or miR-150mut vectors were co-transfected into E10 cells with 15 ng pGL3. After two days, the 
dual-luciferase were determined. (C) 170 ng pENTR/CMV-primiRNA plasmids (miR-150 or 
control) and 15 ng P2X7R full length 3’UTR plasmids were cotransfected into A549 or R3/1 cells, 
along with 15 ng pGL3 plasmids for normalization. Luciferase activities were measured after 48 
hours. Data were expressed as the ratio of Renilla reporter activity to Firefly reporter activity 
(Normalized RL/FL).  The results shown were means ± S.E. (n=6 for panel A, and n=3 for others, 
* P< 0.05 v.s. control, # P<0.05 vs A549 control, & P<0.05 v.s. R3/1 control.)  
 
TargetScan predicts that two miR-150 binding sites exist in the human P2X7R 3’-UTR. To 
determine which site miR-150 interacts with, we constructed truncated P2X7R 3’-UTR only 








































































150B2, RL-P2X7R-150B1mut, and RL-P2X7R-150B2mut). MiR-150 down-regulated the 
luciferase activities of RL-P2X7R-150B2 but failed to inhibit the activities of RL-P2X7R-150B1 
(Fig.V.3A and 3B). Mutation on miR-150 binding site 2 rescued the luciferase activity to control 
level (Fig.V.3B). Consistently, mutation of miR-150 failed to repress the reporter activities of RL-
P2X7R-150B2.  
 
Fig.V.3 The binding site of miR-150 on P2X7R 3’-UTR. (A) 15 ng truncated P2X7 3’UTR plasmids 
containing wild-type or mutated miR150 binding site 1 (RL-P2X7R-150B1 and RL-P2X7R-
150B1mut) (A),  or truncated P2X7 3’-UTR plasmids containing wild-type or mutated miR-150 
binding site 2 (RL-P2X7R-150B2 and RL-P2X7R-150B2mut) (B) were transfected into E10 cells 
with 170 ng pENTR/CMV-EGFP-primiRNA (control vector, miR-150 or miR-150mut) and 15 ng 
pGL3. The dual-luciferase activity was measured 48 hours after transfection. The results were 
normalized to Firefly luciferase activity. The data were means ± S.E. (n=3, *P< 0.05 v.s. control).  
 
 To determine whether miR-150 and miR-186 down-regulate endogenous P2X7R protein 
expression, we generated adenoviruses to overexpress miR-150 and miR-186. These viruses 
were used to transduce E10 cells for 4 days at a MOI of 50 or 100. As shown in Fig.V.4A, the 
P2X7R protein expression was not affected in the control and miR-186 expressing adenoviruses-
treated cells. However, a significant decrease was observed in miR-150 expressing adenovirus-
transduced cells. This decrease was virus dose-dependent. We also examined the P2X7R mRNA 
expression using real-time PCR. The control and miR-150 viruses had no effects on the P2X7R 
mRNA expression. MiR-186 viruses slightly increased the P2X7R level at both protein and mRNA 






















































Fig.V.4 miR-150 silences the P2X7 protein expression. E10 cells were treated with different dose 
of miR-186 and miR-150 overexpressing viruses. A virus overexpressing GFP was used as a 
virus control (VC).  Four days after treatement, protein (A) and mRNA (B) expression were 
examined using Western blot and Real-time PCR. -actin were used as an internal control for 
western blot. 18S rR NA was used as an internal control for real-time PCR. For panel B, data 
are means ±S.E. (n=3 biological replicatios plus 2 technical replications).  
 
5.4.2 Characterizaion of miR-150 expression 
 MiR-150 is highly expressed in lymph nodes, spleen, heart, and brain. However, its 
abundance in the lung is contradictory (35; 37). We first examined the expression of miR-150 in 
various organs by real-time PCR. As previously reported, miR-150 was highly expressed in 















































Fig.V.5 Expression level of miR-150 in organs. Total RNA were extracted from various organs, 
poly (A) tailed and reversed-transcripted into cDNA. Real-time PCR were used to examine the 
miR-150 level. The results were normalized to U2. The data were expressed as means ± S.E. 
(n=3 biological replications plus 2 technical replications)  
 
MiR-150 expression level in type II cells was much higher than type I cells, which was 
inversely correlated with the P2X7R protein level (Fig.V.6A). MiR-150 was also highly expressed 
in the type I cell line, R3/1 that contained little P2X7R, in comparison with that in another type I 
cell line, E10 that contained a high level of P2X7R (Fig.V.6B). These results indicate that P2X7R 
may be a potential target of miR-150.  
 
Fig.V.6 miR-150 and P2X7R expression in lung cells. Total RNA and proteins were extracted 
from AEC II (freshly isolated type II cells) and AEC I (trans-differentiated type I cells by culturing 
AEC II on plastic dishes for 5 days) (A), and E10 and R3/1 cells (B). miR-150 level was 
determined by real-time PCR. U2 was used as an internal reference. The results were expressed 
as means ± S.E. (n=6 except R3/1, n=2) P2X7R protein level was measured by Western blot and 
-actin was used a loading control.  
 
5.4.3 MiR-150 interrupted the P2X7R-mediated surfactant secretion 
 Previously, we found that BzATP activated P2X7R in AEC I, resulting in an increase in 
surfactant secretion in AEC II. We therefore examined whether miR-150 affects surfactant 
secretion. We pre-treated E10 cells with miR-150 or miR-186 overexpression viruses for 4 days 




















stimulate surfactant secretion in AEC II. As shown in Fig.V.7, miR-150 significantly decreased the 
surfactant secretion in AEC II. Interestingly, miR-186 also reduced surfactant secretion.  
  
 
Fig.V.7 MiR-150 inhibits P2X7R-evoked surfactant secretion. (A) E10 cells were treated with 100 
MOI of adenovirus expressing miR-150 or miR-186 for 4 days. Adenovirus only express EGFP 
was used as a control. E10 cells were stimulated for 2 hours with BzATP (25 µM). The E10 cell 
conditioned media were used to stimulate AEC II for 2 hours. PC secretion was measured. Data 
are means ± S.E. (n=3 student’s t test, * P< 0.001 vs. control).  
 
5.5 Discussion 
 The main purpose of this study is to identify miRNAs that regulate the P2X7R activity. 
Using dual-luciferase assay, we first explored the miRNAs which may target to P2X7R. Only miR-
150 consistently inhibited the reporter gene expression. Next, we characterized the miR-150 
expression in different cells. We found that miR-150 had much lower expression in P2X7R-
enriched cells, such as AEC I and E10 cells, further supporting the miR-150 regulation of P2X7R. 
MiR-150 expressing adenovirus dramatically decreased the endogenous P2X7R expression in 
E10 cells. The conditioned media from miR-150 expressing virus treated E10 cells failed to 
stimulate surfactant secretion in AEC II. Our data suggests a possible role of miRNA-150 in 
surfactant secretion.  




















MiRNAs non-perfectly bind to the 3’-UTR of a target mRNA. In many cases, miRNAs only 
repress the mRNA translation by preventing the initiation of translation, disrupting the assembly of 
80S ribosome (9) without degrading the mRNA, or by directly physical destruction of the mRNA 
(24). The features of the miRNA determine that it may have more than one target. Similarly, the 
mRNA can be regulated by several miRNAs. In addition, miRNA regulatory machinery changes 
with cell type and organisms.  
 Among the miRNAs tested, we found that only miR-150 significantly decreased the P2X7R 
3’-UTR reporter expression in rat, mouse and human lung epithelial cells. Mutation of miR-150 
lost the inhibitory effect on P2X7R expression. Our results indicate that the regulation of P2X7R 
by miR-150 is specific and conserved among different species. Consistent with the luciferase 
assay, we also showed that adenovirus expressing miR-150 down-regulated the P2X7R protein 
expression. MiR-150 failed to regulate the luciferase activities of the P2X7R binding site 1, 
indicating that the regulation of P2X7R by miR-150 was through the binding site 2. However, 
mutation of miR-150 could not regulate the mutated P2X7 3’-UTR. According to the mechanisms 
of miRNA processing: three crucial steps are needed: Drosha cleaves pri-miRNA into pre-miRNA; 
Dicer further cleaves pre-miRNA into 21-23 nt double-strand miRNA; and one strand of miRNA is 
loaded into RISC (17). One possible explanation is that mutated miRNA sequence affects the 
miRNA processing. For example, the miRNA cannot be cleaved properly, thus no mature mutated 
miR-150 is synthesized. Alternatively, the mature miRNA cannot be loaded into RISC. 
According to our results, adenovirus expressing miR-150 decreased the endogenous P2X7R 
protein expression for more than 70%, the 3’-UTR reporter assay only showed around 25% 
decrease. There are two possible explainations. First, the transfection efficiency of E10 cells is 
only around 35%. It is possible that the miR-150 and P2X7 3’-UTR vectors were transfected into 
different cells. Thus not all the 3’-UTR plasmids are available for miR-150 inhibition. Second, E10 
cells itself have a very high P2X7R expression. The endogenous P2X7R 3’-UTR may compete 
with the P2X7R 3’-UTR plasmids for miR-150.  
The expression of miR-150 and P2X7R are consistent with their regulatory relationship. MiR-
150 has relatively high expression in spleen, lung, brain, and heart, and a little in kidney and liver. 
P2X7R is initially identified in immune systems as a ion channel, and it mediates programmed cell 
death by releasing IL-1 beta from macrophages (7; 21). Similarly, miR-150 is highly expressed in 
the mature B and T cells. MiR-150 is a key regulator of the B cell maturation and differentiation. 
Overexpression of miR-150 in hematopoietic stem cells impairs the B cell development and 
differentiation by silencing the expression of c-Myb (35; 37). B cells produce antibodies against 
antigens and mediate a specific immune response. P2X7R is involved in the macrophage-
mediated non-specific defense which helps to initiate the specific immune response. The high 
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expression of miR-150 in B cells may down-regulate the P2X7R expression and inhibit the 
subsequent non-specific cation influx and apoptosis.  
Previously using a AEC I and AEC II mixed cell culture model, we found that P2X7R is 
involved in the ATP-induced surfactant secretion (23). E10 cell line is a mouse epithelial type I 
cell line which has high expression of P2X7R and low miR-150 expression. BzATP activates 
P2X7R and stimulates ATP release from E10 cells. The conditioned media from the BzATP-
stimulated E10 cells increased the surfactant secretion of freshly isolated AEC II. If pre-treated 
the E10 cells with virus expressing miR-150 for 4 days, the P2X7R protein level in E10 cells were 
significantly decreased. As a result, surfactant secretion was reduced.  
Pre-treatment of E10 cells with miR-150 and miR-186 overexpression viruses both 
significantly decreased the surfactant secretion from AEC II. However, miR-186 did not reduce 
the P2X7R protein level as miR-150 did, indicating that P2X7R is not a target of miR-186 in lung 
cells. Thus, the regulation of surfactant secretion by miR-186 must be via a different target. Since 
BzATP-stimulated conditioned medium was used for surfactant secretion, miR-186 may target a 
protein that regulates P2X7R-mediated release of a soluble factor.                                                          
In summary, miR-150 regulates the P2X7R expression and thus surfactant secretion. Our 
results verified that P2X7R is a target for miR-150 at protein level. Abnormal surfactant secretion 
may cause severe lung disease. Our results may provide new therapeutic strategies for lung 
diseases related to surfactant secretion.  
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DIFFERENTIATION BETWEEN AMPLICON POLYMERIZATION AND NONSPECIFIC 
PRODUCTS IN SYBR GREEN I REAL-TIME POLYMERASE CHAIN REACTION 
 
6.1 Article 
Real-time PCR is a well-established method for the quantification of gene expression 
levels in biological samples (4; 7; 9)]. The amount of PCR products (amplicons) can be detected 
in real time by measuring fluorescence (6)]. The mRNA levels of the unknown samples can be 
calculated from the cycle threshold (Ct) by either absolute or relative methods (1)]. SYBR Green I 
is a commonly used fluorescent dye to monitor PCR products based on its ability to emit a 
fluorescent signal upon binding to double-strand DNA (5; 12)]. This method sometimes is 
comprised by non-specific signals derived from non-specific amplifications or primer dimers. The 
effects of primer dimers can be eliminated by including a data acquisition step at a higher 
temperature than the annealing temperature (11)], although the latter sometimes may reduce the 
amplification efficiency. Non-specific amplification is mainly caused by non-specific primers, but 
sometimes also by a low annealing temperature and high concentrations of template DNA, Mg2+, 
polymerase, or dNTPs (2)].  
A melting curve is used to assess the specificity of the PCR products. A single peak is 
considered to be specific. Although in some cases, internal melting domains generate a complex 
melting curve (10)], the appearance of multiple peaks usually indicate non-specific amplifications. 
In this study, we observed that, for some genes, in addition to the amplicon peak, higher 
temperature peaks appeared at high copy numbers on the melting curve. We presented evidence 
that this is not due to non-specific amplification, but amplicon polymerization. We also provided a 




The upstream and downstream primers of rattus norvegicus nasal embryonic LHRH 
factor (Nelf, NM_057190) and alcohol dehydrogenase 1 (Adh1, NM_019158) were located in two 
different exons to avoid the amplication from genomic DNA due to the contamination of the RNA 
samples; blast search indicated that they were specific to the respective genes. Aquaporin 8 
(Aqp8) was used as a control to show non-specific amplifications and its forward primer was 
highly homogenous to another gene (Notch 1). The primer sequences are as follows: Nelf: 
forward, TTTGCCAAAGTGGAGAAGGAA, and reverse, CCCATGATGTGGATGACATTTG; 
Adh1: forward, CGGTTAGTGGATCCCTGTTCA, and reverse, 
TATCACCTGGTTTCACACAAGTCA; Aqp8: forward, AGAGTCTAGCGGACCAGTCTGAGT, and 
reverse, CCTTGATCTCACGTAGGTCCATACT. For Nelf and Adh1, the PCR products by 
conventional PCR were purified from agarose gel and used as templates. For Aqp8, the PCR 
products have multiple bands and different dilutions of adult rat lung tissue cDNA were used 
directly as templates. Real-time PCR was performed on an ABI 7500 system using SYBR Green I 
detection (Qiagen, Valencia, CA). The thermal condition was 95oC for 15 min, followed by 40 
cycles of 95oC 20 sec, 60oC for 30 sec, 72oC for 30 sec, and data acquisition at 78oC for 35 sec.  
The melting curve of Nelf showed that there was peak at 79.6 ± 0.2°C for all template 
concentrations (Fig.1B). All amplicons had one band of 100 bp on agarose gel (Fig.VI.1C). This 
represents a typical specific amplification. For Adh1, when template copy number was  100, a 
single peak was observed at 81.7ºC. As the template copy number increased, an additional peak 
appeared at higher temperatures. At  104 copy number, only the higher temperature peak 
remained (83.9 ºC) (Fig.VI.1E). On agarose gel, the amplicons from 104 to 107 copy numbers 
formed a smear, but the amplicons from 10 to 102 copy numbers had an expected single band of 
~110 bp (Fig.VI.1F).  
In order to figure out why there was a shift of Tm and why smears was formed in the PCR 
products of Adh1, we ran another real-time PCR for Adh1 under the same conditions for only 25 
cycles, at which point, the reactions, containing the templates with 105 or lower copy numbers, 
were not saturated. Melting curve analysis showed that the Tm of 105 copy number template 
switched back to 81.7oC from 83.9oC (Fig.VI.1H). On agarose gel, the amplicons from 105 copy 
number template, which formed smears in the previous 40-cycle amplification, had only one band 
(~110 bp) for the 25-cycle amplification (Fig.VI.1I). Although the PCR products from 107 and 106 
copy number templates still had multiple bands, they were not smears anymore. These additional 
bands from 107 and 106 copy numbers were ~220, ~330 and ~440 bp, respectively, which 
correspond to the sizes of dimers, trimers and tetramers of the specific amplicons. In order to 
further confirm that the additional bands are indeed due to the polymerization of the amplicons. 
110 bp and 220 bp bands were purified from the agarose gel and cloned into the PCR®-Blunt 
(Invitrogen) through blunt ligation. After sequencing these PCR products, we found that the 110 
bp band was the amplicon and 220 bp band was a dimer of the amplicon through three 
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nucleotides TGA.  The hotstartTaq polymerase in the Quanti
A at the 3’ end of the PCR products (in few cases other nucleotides), but
5' exonuclease activities to remove the randomly filled nucleotides 
to the polymerization of amplicons. The 
3 linked GC (4 of 6) at the 5’ end of one of the primers, which possibly make it easier to add extra 
nucleotides at the end of the PCR products. The Tm shift derived from the PCR product 
polymerization can be distinguished from a real non
amplifications have distinct peaks in the melting curves and different bands at all the template 
copy numbers (Fig.VI.1K and L), whereas the amplicon polymerization has a gradual
and forms smears only at high template copy numbers (Fig.VI.1F). 
Is the quantification from Adh1
time PCR uses Ct for quantification, 
amplification and far away from saturation. Agarose gel and melting curve analysis are the end 
point analyses; even the polymerized PCR products appear at the end point, they do not interfere 
with the starting point (CT) analyses. The standard curve of
slope of -3.4, indicating a 96.8% amplication efficiency. This is within the range of the acceptable 
slope (-3.0 to -3.9). In order to further confirm the reliability of the standard curve, we did series 
dilutions of new born rat lung tissue cDNA, which generate a single peak (81.7ºC) at all the 
dilutions in the melting curve because their low copy numbers of Adh1 in those samples, and 
quantitated the Adh1 expression. We found that log
log10 (cDNA concentration) generate a curve with an R square of 0.995 and a slope of 1.02. 
Furthermore, we compared the Adh1 expression quantitated from real
DNA microarray, and found the fold changes from each pair of 6 sampl
consistency between two methods.  In our studies, we have run a total of 38 genes using real
time PCR. We found that 28 genes had a specific amplification, 6 genes amplicon polymerization, 
and 4 genes non-specific amplification.
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Fig.VI.1. Amplification, melting curve, and agarose gel electrophoresis of target genes. 
Nelf (A–C) and Adh1 (D–F) were amplified 40 cycles with series dilutions of PCR products as 
template (STD). (G and H). Real-time PCR for Adh1 was run with 25 cycle amplification under the 
same conditions as those in D–F. Aqp8 was run as a nonspecific control using series dilutions of 
adult lung tissue (ALT) cDNA as templates. The data collection temperature for real-time PCR 
was 78 °C. The arrows represent DNA markers. 
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
6.2 Reference List 
 
 1.  Bustin SA. Absolute quantification of mRNA using real-time reverse transcription 
polymerase chain reaction assays. J Mol Endocrinol 25: 169-193, 2000. 
 2.  Carbonari M, Sbarigia D, Cibati M and Fiorilli M. Optimization of PCR performance. Trends 
Genet 9: 42-43, 1993. 
 3.  Clark JM. Novel non-templated nucleotide addition reactions catalyzed by procaryotic and 
eucaryotic DNA polymerases. Nucleic Acids Res 16: 9677-9686, 1988. 
 4.  de Kok JB, van Balken MR, Roelofs RW, van Aarssen YA, Swinkels DW and Klein 
Gunnewiek JM. Quantification of hTERT mRNA and telomerase activity in bladder 
washings of patients with recurrent urothelial cell carcinomas. Clin Chem 46: 2003-2007, 
2000. 
 5.  Giglio S, Monis PT and Saint CP. Demonstration of preferential binding of SYBR Green I to 
specific DNA fragments in real-time multiplex PCR. Nucleic Acids Res 31: e136, 2003. 
 6.  Holland PM, Abramson RD, Watson R and Gelfand DH. Detection of specific polymerase 
chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus 
DNA polymerase. Proc Natl Acad Sci U S A 88: 7276-7280, 1991. 
 7.  Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, 
Buchanan ME, Muller A, deWaal MR, Deng G, Orozco R, Ruzicka T, Lehmann P, 
Lebecque S, Caux C and Zlotnik A. Up-regulation of macrophage inflammatory protein-3 
alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164: 6621-6632, 2000. 
 8.  Hu G. DNA polymerase-catalyzed addition of nontemplated extra nucleotides to the 3' end 
of a DNA fragment. DNA Cell Biol 12: 763-770, 1993. 
 9.  Kubo A, Nishitani Y, Minamino N, Kikumoto K, Kurioka H, Nishino T, Iwano M, Shiiki H, 
Kangawa K and Dohi K. Adrenomedullin gene transcription is decreased in peripheral 
blood mononuclear cells of patients with IgA nephropathy. Nephron 85: 201-206, 2000. 
 10.  Li W, Xi B, Yang W, Hawkins M and Schubart UK. Complex DNA melting profiles of small 
PCR products revealed using SYBR Green I. Biotechniques 35: 702-4, 706, 2003. 
 11.  Morrison TB, Weis JJ and Wittwer CT. Quantification of low-copy transcripts by continuous 
SYBR Green I monitoring during amplification. Biotechniques 24: 954-8, 960, 962, 1998. 
 12.  Ririe KM, Rasmussen RP and Wittwer CT. Product differentiation by analysis of DNA 
melting curves during the polymerase chain reaction. Anal Biochem 245: 154-160, 1997. 
 
6.7 Acknowledgements 
We are grateful to Dr. Nili Jin for her assistance with the real-time PCR and manuscript writing. 
This work was supported by NIH R01 HL-52146 and R01 HL-071628 (to L.L.). N.J. was 
supported by an AHA predoctoral fellowship (0315256Z). 
  

Fetal lung development is a complex and important biological process which includes the 
interactions among growth factors, transcription factors and extracellular matrix proteins. The 
maturation of AEC II and AEC I happens during the late stages of fetal l
(Canalicular and Saccular stages). The differentiation of these two cells is crucial for normal lung 
function. The signaling pathways 
have been studied to some extent. However, wh
which also regulate these processes is not known. 
The present study was first designed to explore the genes which have expression changes 
during the late stages of fetal lung development. From there, we found
a potential candidate. In the second part of the work, we studied the function of PTN including 
fetal AEC II proliferation, migration and trans
PTN was also examined. Next, 
in fetal lung development using PTN
important aspect of lung development
In the fourth part, we examined how microRNA
In our first set of studies, we want to
during fetal lung development
expression changes on embryonic day 18, 19, 20, 21, new born and adult. Statistical significance 
analysis of microarray (SAM) test identified 583 genes with >2 fold change between at least two 
time points and coefficient of variation 
One of these clusters was identified as a “developing” cluster, which only contains 10 known 
genes, but 7 of these 10 known genes are involved in development or cell proliferation. The 
expression of this group of genes increased from E18 to E20 and decreased after that
time PCR analysis of these 10 known genes showed an 88% consistency with the microarray 
data. We further examined the cellular localization of LIM homeodomain protein 3a (L
transcription factor, and PTN, a Heparin
immunohistochemistry. Lhx3 was mainly located in the developing airway epithelial cells, while 
PTN in the mesenchymal cells adjacent to the developin
GenMAPP, we identified four regulatory
inflammatory response, cell cycle, and G protein signaling. We also identified




SUMMARY AND CONCLUSIONS 
 
that regulate fetal lung development and AEC differentiation 
ether there are additional signaling molecules 
 
 that pleiotrophin (PTN) is 
-differentiation into AEC I. The signaling pathway of 
in vivo studies were further carried out to examine the role of PTN 
-/- mice. Since the regulation of surfactant secretion is an 
, we next carried out some studies on surfactant secretion
-150 regulates surfactant secretion via P2X7R.
 screen genes which may regulate AEC II differentiation 
. We used a loop-designed 10K DNA microarray to explore gene 
less than 0.5. These genes were clustered into 7 clusters. 
-binding cytokine, using real
g epithelium and endothelial cells. Using 







-time PCR and 
-  signaling, 
 two metabolic 
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Since the expression pattern of PTN indicated that it may be involved in the epithelial-
mesenchymal interactions, in the second set of studies, we examined the cellular localization of 
PTN receptor, protein tyrosine phosphatase receptor / (RPTP/). RPTP/ was highly 
expressed in epithelial cells of the fetal lungs.  Using isolated fetal alveolar epithelial type II cells, 
we demonstrated that human recombinant PTN increased wound healing of injured fetal AEC II 
monolayer,   promoted fetal AEC II proliferation and arrested AECII trans-differentiation into AEC 
I. Silencing of PTN expression influenced lung branching morphogenesis in a fetal lung organ 
culture model. PTN signaling pathway through RPTP//-catenin was also examined. PTN 
increased the tyrosine phosphorylation of -catenin, promoted -catenin translocation into the 
nucleus and activated TCF/LEF transcription factors. We also examined whether PTN regulates 
-catenin downstream genes. These studies revealed that pleiotrophin/-catenin pathway 
suppressed endogenous dlk1 expression. Promoter assay and chromatin immunoprecipitation 
further verified -catenin as a potential regulator of dlk1. Our results demonstrated that PTN plays 
roles in fetal lung development by regulating AEC II migration, proliferation and differentiation 
through RPTP//-catenin pathway. 
In our third set of studies, we examined the lung morphology and marker gene expression 
during the development using PTN knockout (PTN-/-) and wild-type (PTN+/+) mice. No obvious 
difference was observed between PTN-/- and PTN+/+ mouse lungs during the fetal and early 
postnatal stages when PTN expression was high. However, on postnatal day 15 and adult, HE 
staining showed that PTN-/- mice had hypercellular lungs with smaller alveoli and thicker septa in 
comparison with those of PTN+/+ mice of the same age. These findings indicated that lungs of 
PTN-/- mice were less matured and developed. -SMA, a myofibroblast makrer, had significantly 
higher expression in PTN-/- mice lungs on P15 and adult. Real-time PCR showed that SP-A, B, 
and C, and CCSP all significantly increased in adult PTN-/- mouse lungs, while P2X7R and T1- 
expression decreased. Our data demonstrate for the first time that PTN may play an important 
role in the alveolarization that occurs during lung development. 
In our forth set of studies, we determined whether miRNA regulates P2X7R-mediated 
surfactant secretion. The development of pulmonary surfactant system is a crucial part of the 
normal lung development. First, using a dual-luciferase assay, we screened the regulation of 
P2X7R 3’UTR activity by miR-150, miR-186, miR-204 and miR-211 in lung epithelial cells. Only 
miR-150 consistently suppressed P2X7R 3’UTR reporter activity. Site mutation of mature miR-
150 or mutation of P2X7R 3’-UTR at miR-150 binding sites both disrupted the miR-150 
regulation, indicating the specificity of miR-150 on P2X7R repression. We also constructed an 
adenovirus to express miR-150. This virus significantly downregulated the endogenous P2X7R 
protein expression in E10 cells, and subsequently disrupted the surfactant secretion stimulated by 
E10 cell conditioned media. Our study is the first of its kind to demonstrate that miR-150 
regulates P2X7R-mediated surfactant secretion in AEC II.  


The last set of studies is a by-product derived from this dissertation research. Real-time PCR 
is a potential tool to examine gene expression in cells and organs. In this study, higher 
temperature peaks were observed in additional to the amplicon peak on the melting curve. 
Agarose gel and following DNA sequencing indicated that this was due to amplicon 
polymerization instead of nonspecific amplification. We also provided a method to distinguish 
between amplicon polymerization and nonspecific amplification.  
 In summary, our results demonstrated for the first time that PTN plays an important role 
in fetal lung development. It regulates fetal type II cell proliferation, migration and differentiation at 
least partly through -catenin pathways. In vivo studies further confirmed that PTN influences the 
lung alveolorization by regulating cell proliferation and differentiation. Finally, miR-150 was 
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Scope and Method of Study: 
The present study was initiated to identify novel growth factors which regulate the fetal lung 
development. A loop-designed DNA microarray was used to examine the changed gene 
expression on embryonic day 18, 19, 20, 21, newborn and adult. From DNA microarray, we 
identified pleiotrophin (PTN) as a growth factor which is involved in AEC II differentiation during 
fetal lung development. Functional studies were carried out to examine the role of PTN on 
primary fetal AEC II proliferation, migration and trans-differentiation. The signaling pathway of 
PTN through RPTP/ and beta-catenin was also determined by measuring -catenin tyrosine 
phosphorylation and nuclear translocation. PTN was silenced on fetal lung organ culture using 
RNA interference to check the role of PTN on lung branching morphogenesis. Furthermore, PTN 
knockout mice were used to examine the role of PTN on fetal lung development in vivo. P2X7R is 
previously identified to mediate surfactant secretion from AEC II. Finally, we examined how miR-
150 regulates surfactant secretion via P2X7R.  
Findings and Conclusions: 
1. The expression of 583 genes were significantly changed during the fetal lung development 
with >2 fold changes between at least two time points and CV <0.5. 
2. K-means cluster analysis identified 7 different expression patterns. 
3. The gene expression of one cluster was verified using real-time PCR with 88% consistency 
with microarray data.  
4. PTN was localized in the mesenchymal cells surrounding the developing epithelium and 
blood vessel.  
5. PTN promoted the fetal AEC II proliferation and migration, but inhibited the fetal AEC II trans-
differentiation into AEC I.  
6. Silencing of PTN expression affects the lung branching morphogenesis on fetal lung organ 
culture. 
7. PTN increased the tyrosine phosphorylation of -catenin, promoted -catenin translocation 
into the nucleus and activated TCF/LEF transcription factors. 
8. The activation of PTN/-catenin pathway decreased endogenous dlk1 expression, inhibited 
the Dlk1 promoter activity and the binding of -catenin to the Dlk1 promoter.  
9. PTN-/- mice had no abnormalities during fetal and early postnatal stages.  
10. On postnatal day 15 and 35, the lungs of PTN-/- mice showed hyperplasia with smaller alveoli 
and thicker septa. 
11. On postnatal day 15 and 35, the expression of SP-A, -B, -C, CC10 and -SMA were 
upregulated in PTN-/- lung, while T1- and P2X7R were downregulated .  
12. 3’-UTR dual-luciferase assay identified miR-150 as a regulator of P2X7R in lung epithelial 
cells.  
13. The regulation of miR-150 was disrupted by mutation of miR-150 or P2X7R 3’UTR at miR-
150 binding site. 
14. Pre-treating E10 cells with adenovirus expressing miR-150 disrupted the surfactant secretion 
stimulated by E10 cell conditioned media.  
 
